<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01240902</url>
  </required_header>
  <id_info>
    <org_study_id>MCV-US-2009-01</org_study_id>
    <nct_id>NCT01240902</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in High Risk and Very High Risk Subjects Who Need Aortic Valve Replacement</brief_title>
  <official_title>Medtronic CoreValve® U.S. Pivotal Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic Cardiovascular</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic Cardiovascular</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to evaluate the safety and efficacy of the Medtronic CoreValve®
      System in the treatment of symptomatic severe aortic stenosis in subjects who have a
      predicted high risk for aortic valve surgery and/or very high risk for aortic valve surgery.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>November 2010</start_date>
  <completion_date type="Anticipated">August 2020</completion_date>
  <primary_completion_date type="Actual">August 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Extreme Risk: All-cause Death or Major Stroke; High Risk Surgical: All-cause Mortality</measure>
    <time_frame>1 year</time_frame>
    <description>All-cause Death or Major Stroke (Extreme Risk- Medtronic CoreValve® System); All-cause Mortality (High Risk Surgical- Medtronic CoreValve® System vs. Surgical Valve)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Major Adverse Cardiovascular and Cerebrovascular Event (MACCE)</measure>
    <time_frame>30 day, 6 month, 1 year, 2 year</time_frame>
    <description>MACCE is defined as a composite of:
All Cause Mortality
Myocardial infarction (MI)
All Stroke
Reintervention (defined as any cardiac surgery or percutaneous reintervention catheter procedure that repairs, otherwise alters or adjusts, or replaces a previously implanted valve)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Occurrence of Individual MACCE Components</measure>
    <time_frame>30 day, 6 month, 1 year, 2 year</time_frame>
    <description>Individual MACCE Components Include:
All Cause Mortality
MI
All stroke
Reintervention (defined as any cardiac surgery or percutaneous reintervention catheter procedure that repairs, otherwise alters or adjusts, or replaces a previously implanted valve)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major Adverse Events (MAEs)</measure>
    <time_frame>30 day, 6 month, 1 year, 2 year</time_frame>
    <description>MAEs Include:
MACCE
Acute Kidney Injury
Cardiac Tamponade
Prosthetic Valve Dysfunction
Cardiogenic Shock
Valve Endocarditis
Life-Threatening, Disabling or Major Bleeding
Major Vascular Complication
Cardiac Perforation
Device Migration/Valve Embolism</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Conduction Disturbance Requiring Permanent Pacemaker Implantation</measure>
    <time_frame>30 day, 6 month, 1 year, 2 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in NYHA Class</measure>
    <time_frame>30 day, 6 month, 1 year, 2 year</time_frame>
    <description>Change from baseline (continuous variable). A positive number corresponds to NYHA worsening; a negative number corresponds to NYHA improvement.
New York Heart Association (NYHA) Classification:
Class I: Subjects with cardiac disease but without resulting limitations of physical activity.
Class I: Subjects with cardiac disease resulting in slight limitation of physical activity.
Class III: Subjects with cardiac disease resulting in marked limitation of physical activity.
Class IV: Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Distance Walked During 6-Minute Walk Test (6MWT)</measure>
    <time_frame>30 day, 1 year</time_frame>
    <description>Change in distance walked during 6MWT from baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ratio of Days Alive Out of Hospital Versus Total Days Alive</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life (QoL) Change</measure>
    <time_frame>30 day, 6 month, 1 year, 2 year</time_frame>
    <description>QoL summary score change from baseline using the following measures:
Kansas City Cardiomyopathy Questionnaire (KCCQ): Quantifies physical function, symptoms, social function, self-efficacy and knowledge, and quality of life. Scores are transformed to a range of 0-100, in which higher scores reflect better health status.
12 Item Short Form Health Survey (SF-12): Measures functional health and well-being. Scores are transformed to a range of 0-100, in which higher scores reflect better health status.
European QoL (EQ-5D): Measures 5 domains (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) that can be converted to utilities using an algorithm. Utilities range from 0 to 1, with 1 representing perfect health, and 0 corresponding to the worst imaginable health state.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Echocardiographic Assessment of Valve Performance</measure>
    <time_frame>30 day, 6 month, 1 year, 2 year</time_frame>
    <description>Using the following measures:
- Effective Orifice Area (EOA)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Echocardiographic Assessment of Valve Performance</measure>
    <time_frame>30 day, 6 month, 1 year, 2 year</time_frame>
    <description>Using the following measures:
- Transvalvular Mean Gradient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Echocardiographic Assessment of Valve Performance</measure>
    <time_frame>30 day, 6 month, 1 year, 2 year</time_frame>
    <description>Using the following measure:
- Degree of Aortic Valve Regurgitation (Transvalvular and Paravalvular)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aortic Valve Hospitalizations</measure>
    <time_frame>30 day, 6 month, 1 year, 2 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular Deaths and Valve Related Deaths</measure>
    <time_frame>30 day, 6 month, 1 year, 2 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Strokes and Transient Ischemic Attacks (TIAs)</measure>
    <time_frame>30 day, 6 month, 1 year, 2 year</time_frame>
    <description>Strokes (of any severity) and TIAs</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Index Procedure Related MAEs</measure>
    <time_frame>Procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of Index Procedure Hospital Stay</measure>
    <time_frame>Number of days from admission to discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Device Success</measure>
    <time_frame>Number of days from admission to discharge</time_frame>
    <description>Medtronic CoreValve® System subjects only.
Defined as:
Successful vascular access, delivery and deployment of the device, and successful retrieval of the delivery system,
Correct position of the device in the proper anatomical location (placement in the annulus with no impedance on device function),
Intended performance of the prosthetic valve (aortic valve area &gt; 1.2 cm2 for 26, 29 and 31mm valves, ≥ 0.9 cm2 for 23mm valve (by echocardiography using the continuity equation) and mean aortic valve gradient &lt; 20 mmHg or peak velocity &lt; 3 m/sec, without moderate or severe prosthetic valve aortic regurgitation)
Only one valve implanted in the proper anatomical location</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedural Success</measure>
    <time_frame>Number of days from admission to discharge</time_frame>
    <description>Medtronic CoreValve® System subjects only.
Defined as device success and absence of in-hospital MACCE.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prosthetic Valve Dysfunction (PVD)</measure>
    <time_frame>30 day, 6 month, 1 year, 2 year</time_frame>
    <description>PVD was defined according to VARC I using the Core Lab Echocardiography assessments including aortic regurgitation (AR) and aortic stenosis (AS) evaluations. Total AR reported as moderate or severe was considered PVD. AS was defined as significant stenosis and considered PVD if one of the following was met:
Peak velocity &gt;4 m/s
Mean gradient &gt;35 mmHg
EOA &lt; 0.8 cm2
TVIV1 / TVIV2 &lt; 0.25</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">1453</enrollment>
  <condition>Severe Aortic Stenosis</condition>
  <arm_group>
    <arm_group_label>Extreme Risk: TAVI Iliofemoral</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Iliofemoral Access</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Extreme Risk: TAVI Non-Iliofemoral</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Non-Iliofemoral Access</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High Risk: TAVI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>High Risk Surgical Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High Risk: SAVR</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>High Risk Surgical Patients: Surgical Aortic Valve Replacement (SAVR)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</intervention_name>
    <description>Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
    <arm_group_label>Extreme Risk: TAVI Iliofemoral</arm_group_label>
    <arm_group_label>Extreme Risk: TAVI Non-Iliofemoral</arm_group_label>
    <arm_group_label>High Risk: TAVI</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Surgical Aortic Valve Replacement (SAVR)</intervention_name>
    <description>Surgical Aortic Valve Replacement (SAVR)</description>
    <arm_group_label>High Risk: SAVR</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Extreme Risk Only: Subject must have comorbidities such that one cardiologist and two
             cardiac surgeons agree that medical factors preclude operation, based on a conclusion
             that the probability of death or serious morbidity exceeds the probability of
             meaningful improvement. Specifically, the predicted operative risk of death or
             serious, irreversible morbidity is ≥ 50% at 30 days.

          -  High Risk Surgical Only: Subject must have comorbidities such that one cardiologist
             and two cardiac surgeons agree that predicted risk of operative mortality is ≥15% (and
             predicted operative mortality or serious, irreversible morbidity risk of &lt; 50%) at 30
             days.

          -  Subject has senile degenerative aortic valve stenosis with: mean gradient &gt; 40 mmHg,
             or jet velocity greater than 4.0 m/sec by either resting or dobutamine stress
             echocardiogram, or simultaneous pressure recordings at cardiac catheterization (either
             resting or dobutamine stress), AND an initial aortic valve area of ≤ 0.8 cm2 (or
             aortic valve area index ≤ 0.5 cm2/m2) by resting echocardiogram or simultaneous
             pressure recordings at cardiac catheterization

          -  Subject is symptomatic from his/her aortic valve stenosis, as demonstrated by New York
             Heart Association (NYHA) Functional Class II or greater.

          -  The subject or the subject's legal representative has been informed of the nature of
             the trial, agrees to its provisions and has provided written informed consent as
             approved by the IRB of the respective clinical site.

          -  The subject and the treating physician agree that the subject will return for all
             required post-procedure follow-up visits.

        Exclusion Criteria:

        Clinical

          -  Evidence of an acute myocardial infarction ≤ 30 days before the intended treatment.

          -  Any percutaneous coronary or peripheral interventional procedure performed within 30
             days prior to the intended treatment. (High Risk Surgical Only: Including bare metal
             stents. Additionally, any drug eluting stents placed within 6 months prior to the
             index procedure.)

          -  Blood dyscrasias as defined: leukopenia (WBC &lt; 1000mm3), thrombocytopenia (platelet
             count &lt;50,000 cells/mm3), history of bleeding diathesis or coagulopathy.

          -  Untreated clinically significant coronary artery disease requiring revascularization.

          -  Cardiogenic shock manifested by low cardiac output, vasopressor dependence, or
             mechanical hemodynamic support.

          -  Need for emergency surgery for any reason.

          -  Severe ventricular dysfunction with left ventricular ejection fraction (LVEF) &lt; 20% as
             measured by resting echocardiogram.

          -  Recent (within 6 months) cerebrovascular accident (CVA) or transient ischemic attack
             (TIA).

          -  End stage renal disease requiring chronic dialysis or creatinine clearance &lt; 20
             cc/min.

          -  Active Gastrointestinal (GI) bleeding within the past 3 months.

          -  A known hypersensitivity or contraindication to any of the following which cannot be
             adequately pre-medicated:

          -  Aspirin

          -  Heparin (HIT/HITTS)

          -  Bivalirudin (Extreme Risk Only)

          -  Nitinol (titanium or nickel)

          -  Ticlopidine and clopidogrel

          -  Contrast media

          -  Ongoing sepsis, including active endocarditis.

          -  Subject refuses a blood transfusion.

          -  Life expectancy &lt; 12 months due to associated non-cardiac co-morbid conditions.

          -  Other medical, social, or psychological conditions that in the opinion of an
             Investigator precludes the subject from appropriate consent.

          -  Severe dementia (resulting in either inability to provide informed consent for the
             trial/procedure, prevents independent lifestyle outside of a chronic care facility, or
             will fundamentally complicate rehabilitation from the procedure or compliance with
             follow-up visits).

          -  Currently participating in an investigational drug or another device trial.

          -  Symptomatic carotid or vertebral artery disease.

          -  Subject has been offered surgical aortic valve replacement but declined. (High Risk
             Surgical Only)

        Anatomical

          -  Native aortic annulus size &lt; 18 mm or &gt; 29 mm per the baseline diagnostic imaging.

          -  Pre-existing prosthetic heart valve any position.

          -  Mixed aortic valve disease (aortic stenosis and aortic regurgitation with predominant
             aortic regurgitation (3-4+)).

          -  Moderate to severe (3-4+) or severe (4+) mitral or severe (4+) tricuspid
             regurgitation.

          -  Moderate to severe mitral stenosis.

          -  Hypertrophic obstructive cardiomyopathy.

          -  New or untreated echocardiographic evidence of intracardiac mass, thrombus or
             vegetation.

          -  Severe basal septal hypertrophy with an outflow gradient.

          -  Aortic root angulation (angle between plane of aortic valve annulus and horizontal
             plane/vertebrae) &gt; 70° (for femoral and left subclavian/axillary access) and &gt; 30°
             (for right subclavian/axillary access).

          -  Ascending aorta diameter &gt; 43 mm if the aortic annulus diameter is 23-29 mm; ascending
             aorta diameter &gt; 40 mm if the aortic annulus diameter is 20-23 mm; or an ascending
             aorta diameter &gt; 34 mm if the aortic annulus diameter is 18-20 mm.

          -  Congenital bicuspid or unicuspid valve verified by echocardiography.

          -  Sinus of valsalva anatomy that would prevent adequate coronary perfusion.

        Vascular

        - Transarterial access not able to accommodate an 18Fr sheath.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David H Adams, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Icahn School of Medicine at Mount Sinai</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jeffrey J Popma, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beth Israel Deaconess Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Banner Good Samaritan</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85006</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kaiser Permanente - Los Angeles Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90027</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Southern California University Hospital</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>El Camino Hospital</name>
      <address>
        <city>Mountain View</city>
        <state>California</state>
        <zip>94040</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Palo Alto Health Care System</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hartford Hospital</name>
      <address>
        <city>Hartford</city>
        <state>Connecticut</state>
        <zip>06102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yale New Haven Hospital</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06520</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Washington Hospital Center / Georgetown Hospital</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mount Sinai Medical Center</name>
      <address>
        <city>Miami Beach</city>
        <state>Florida</state>
        <zip>33140</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Miami Health System / Jackson Memorial Hospital</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Piedmont Heart Institute</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30309</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Joseph's Hospital of Atlanta</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30342</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Loyola University Medical Center</name>
      <address>
        <city>Maywood</city>
        <state>Illinois</state>
        <zip>60153</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Vincent Heart Center of Indiana</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46290</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Iowa Heart Center</name>
      <address>
        <city>Des Moines</city>
        <state>Iowa</state>
        <zip>50314</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Kansas Hospital</name>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <zip>66160</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiovascular Institute of the South/ Terrebone General</name>
      <address>
        <city>Houma</city>
        <state>Louisiana</state>
        <zip>70360</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins Hospital</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beth Israel Deaconess Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Michigan Health Systems</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Detroit Medical Center Cardiovascular Institute</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. John Hospital and Medical Center</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48236</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spectrum Health Hospitals</name>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <zip>49503</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Morristown Memorial Hospital</name>
      <address>
        <city>Morristown</city>
        <state>New Jersey</state>
        <zip>07962</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North Shore University Hospital/ Long Island Jewish Hospital</name>
      <address>
        <city>Manhasset</city>
        <state>New York</state>
        <zip>11030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NYU Langone Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Mount Sinai Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lenox Hill Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10075</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Francis Hospital</name>
      <address>
        <city>Roslyn</city>
        <state>New York</state>
        <zip>11576</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wake Forest University - Baptist Medical Center</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospitals - Case Medical Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Ohio State University Medical Center - The Richard M. Ross Heart Hospital</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Riverside Methodist Hospital</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43214</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Geisinger Medical Center</name>
      <address>
        <city>Danville</city>
        <state>Pennsylvania</state>
        <zip>17822</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pinnacle Health</name>
      <address>
        <city>Harrisburg</city>
        <state>Pennsylvania</state>
        <zip>17043</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh Medical Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baylor Heart and Vascular Hospital</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75226</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Texas Heart Institute at St. Luke's Episcopal Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Methodist Hospital - The Methodist DeBakey Heart &amp; Vascular Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fletcher Allen Healthcare</name>
      <address>
        <city>Burlington</city>
        <state>Vermont</state>
        <zip>05458</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Inova Fairfax Hospital</name>
      <address>
        <city>Falls Church</city>
        <state>Virginia</state>
        <zip>22042</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Providence Sacred Heart Medical Center</name>
      <address>
        <city>Spokane</city>
        <state>Washington</state>
        <zip>99204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Luke's Medical Center - Aurora Health Care</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.aorticstenosistrial.com</url>
  </link>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 10, 2010</study_first_submitted>
  <study_first_submitted_qc>November 12, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 15, 2010</study_first_posted>
  <results_first_submitted>March 6, 2015</results_first_submitted>
  <results_first_submitted_qc>May 20, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">June 8, 2015</results_first_posted>
  <last_update_submitted>May 7, 2018</last_update_submitted>
  <last_update_submitted_qc>May 7, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Valvular Heart Disease</keyword>
  <keyword>Critical Aortic Stenosis</keyword>
  <keyword>Severe Aortic Stenosis</keyword>
  <keyword>High Risk</keyword>
  <keyword>Aortic Valve Replacement</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Constriction, Pathologic</mesh_term>
    <mesh_term>Aortic Valve Stenosis</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Between Feb 17, 2011 and Aug 23, 2013, 656 subjects were enrolled into the CoreValve US Pivotal Trial Extreme Risk study at 41 of the 43 activated centers in the United States. Between February 2, 2011 and July 23, 2013, 797 subjects were enrolled into the CoreValve US Pivotal Trial High Risk study at 45 centers in the United States.</recruitment_details>
      <pre_assignment_details>The first 3 successfully enrolled and implanted iliofemoral subjects at each implanting site, inclusive of both the High Risk Surgical and Extreme Risk patient populations were considered roll-in subjects, and were automatically assigned to undergo Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI).</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Extreme Risk: TAVI Iliofemoral</title>
          <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Iliofemoral Access</description>
        </group>
        <group group_id="P2">
          <title>Extreme Risk: TAVI Non-Iliofemoral</title>
          <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Non-Iliofemoral Access</description>
        </group>
        <group group_id="P3">
          <title>High Risk: TAVI</title>
          <description>High Risk Surgical Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
        </group>
        <group group_id="P4">
          <title>High Risk: SAVR</title>
          <description>High Risk Surgical Patients: Surgical Aortic Valve Replacement (SAVR)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="500"/>
                <participants group_id="P2" count="156"/>
                <participants group_id="P3" count="395"/>
                <participants group_id="P4" count="402"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="289"/>
                <participants group_id="P2" count="77"/>
                <participants group_id="P3" count="295"/>
                <participants group_id="P4" count="237"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="211"/>
                <participants group_id="P2" count="79"/>
                <participants group_id="P3" count="100"/>
                <participants group_id="P4" count="165"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Participant Population= As Treated (AT) cohort. The AT cohort consisted of all Intent to Treat (ITT) subjects with an attempted implant procedure.</population>
      <group_list>
        <group group_id="B1">
          <title>Extreme Risk: TAVI Iliofemoral</title>
          <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Iliofemoral Access</description>
        </group>
        <group group_id="B2">
          <title>Extreme Risk: TAVI Non-Iliofemoral</title>
          <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Non-Iliofemoral Access</description>
        </group>
        <group group_id="B3">
          <title>High Risk: TAVI</title>
          <description>High Risk Surgical Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
        </group>
        <group group_id="B4">
          <title>High Risk: SAVR</title>
          <description>High Risk Surgical Patients: Surgical Aortic Valve Replacement (SAVR)</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="489"/>
            <count group_id="B2" value="150"/>
            <count group_id="B3" value="391"/>
            <count group_id="B4" value="359"/>
            <count group_id="B5" value="1389"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <description>Participant Population= Consisted of all subjects with an attempted implant procedure.</description>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="83.2" spread="8.7"/>
                    <measurement group_id="B2" value="81.3" spread="7.4"/>
                    <measurement group_id="B3" value="83.2" spread="7.1"/>
                    <measurement group_id="B4" value="83.3" spread="6.4"/>
                    <measurement group_id="B5" value="83.0" spread="7.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <description>Participant Population= Consisted of all subjects with an attempted implant procedure.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="255"/>
                    <measurement group_id="B2" value="82"/>
                    <measurement group_id="B3" value="184"/>
                    <measurement group_id="B4" value="171"/>
                    <measurement group_id="B5" value="692"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="234"/>
                    <measurement group_id="B2" value="68"/>
                    <measurement group_id="B3" value="207"/>
                    <measurement group_id="B4" value="188"/>
                    <measurement group_id="B5" value="697"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <description>Participant Population= Consisted of all subjects with an attempted implant procedure.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>American Indian or Alaska Native</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native Hawaiian or Other Pacific Islander</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="11"/>
                    <measurement group_id="B5" value="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="468"/>
                    <measurement group_id="B2" value="143"/>
                    <measurement group_id="B3" value="387"/>
                    <measurement group_id="B4" value="343"/>
                    <measurement group_id="B5" value="1341"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>More than one race</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="2"/>
                    <measurement group_id="B5" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Surface Area</title>
          <description>Participant Population= Consisted of all subjects with an attempted implant procedure.</description>
          <units>m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.8" spread="0.3"/>
                    <measurement group_id="B2" value="1.8" spread="0.2"/>
                    <measurement group_id="B3" value="1.8" spread="0.2"/>
                    <measurement group_id="B4" value="1.9" spread="0.2"/>
                    <measurement group_id="B5" value="1.8" spread="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>NYHA Classification</title>
          <description>New York Heart Association (NYHA) Classification:
Class I: Subjects with cardiac disease but without resulting limitations of physical activity.
Class I: Subjects with cardiac disease resulting in slight limitation of physical activity.
Class III: Subjects with cardiac disease resulting in marked limitation of physical activity.
Class IV: Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>NYHA I</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NYHA II</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="40"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="57"/>
                    <measurement group_id="B4" value="47"/>
                    <measurement group_id="B5" value="156"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NYHA III</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="313"/>
                    <measurement group_id="B2" value="98"/>
                    <measurement group_id="B3" value="255"/>
                    <measurement group_id="B4" value="250"/>
                    <measurement group_id="B5" value="916"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NYHA IV</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="136"/>
                    <measurement group_id="B2" value="40"/>
                    <measurement group_id="B3" value="79"/>
                    <measurement group_id="B4" value="62"/>
                    <measurement group_id="B5" value="317"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Society of Thoracic Surgeons (STS) Risk Score</title>
          <description>The Society of Thoracic Surgeons (STS) risk model predicts the risk of operative mortality and morbidity after adult cardiac surgery on the basis of patient demographic and clinical variables. After information has been entered on a given case, the online STS risk calculator provides a risk percentage for each of the outcomes. The risk percentage estimates the chance of a specific outcome for a patient with the indicated risk factors. A higher score indicates a higher risk. A lower score indicates a lower risk.</description>
          <units>% risk of mortality or morbidity</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10.3" spread="5.5"/>
                    <measurement group_id="B2" value="10.7" spread="5.7"/>
                    <measurement group_id="B3" value="7.3" spread="3.0"/>
                    <measurement group_id="B4" value="7.5" spread="3.3"/>
                    <measurement group_id="B5" value="8.8" spread="4.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Logistic European System for Cardiac Operative Risk Evaluation (EuroSCORE)</title>
          <description>The European System for Cardiac Operative Risk Evaluation (EuroSCORE) is a method of calculating predicted operative mortality for patients undergoing cardiac surgery. If a risk factor is present, a weight/number is assigned. The weights are added to give an approximate percent of predicted mortality. A higher score indicates a higher risk. A lower score indicates a lower risk.</description>
          <units>%</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22.6" spread="17.1"/>
                    <measurement group_id="B2" value="22.9" spread="15.9"/>
                    <measurement group_id="B3" value="17.7" spread="13.0"/>
                    <measurement group_id="B4" value="18.8" spread="13.2"/>
                    <measurement group_id="B5" value="20.3" spread="15.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Extreme Risk: All-cause Death or Major Stroke; High Risk Surgical: All-cause Mortality</title>
        <description>All-cause Death or Major Stroke (Extreme Risk- Medtronic CoreValve® System); All-cause Mortality (High Risk Surgical- Medtronic CoreValve® System vs. Surgical Valve)</description>
        <time_frame>1 year</time_frame>
        <population>Participant Population= Consisted of all subjects with an attempted implant procedure.</population>
        <group_list>
          <group group_id="O1">
            <title>Extreme Risk: TAVI Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Iliofemoral Access</description>
          </group>
          <group group_id="O2">
            <title>Extreme Risk: TAVI Non-Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Non-Iliofemoral Access</description>
          </group>
          <group group_id="O3">
            <title>High Risk: TAVI</title>
            <description>High Risk Surgical Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O4">
            <title>High Risk: SAVR</title>
            <description>High Risk Surgical Patients: Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>Extreme Risk: All-cause Death or Major Stroke; High Risk Surgical: All-cause Mortality</title>
          <description>All-cause Death or Major Stroke (Extreme Risk- Medtronic CoreValve® System); All-cause Mortality (High Risk Surgical- Medtronic CoreValve® System vs. Surgical Valve)</description>
          <population>Participant Population= Consisted of all subjects with an attempted implant procedure.</population>
          <units>percentage of participants, Kaplan-Meier</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="489"/>
                <count group_id="O2" value="150"/>
                <count group_id="O3" value="391"/>
                <count group_id="O4" value="359"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.0"/>
                    <measurement group_id="O2" value="39.3"/>
                    <measurement group_id="O3" value="14.1"/>
                    <measurement group_id="O4" value="18.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>TAVR with the Medtronic CoreValve System meets the Performance Goal in the 12 month rate of all-cause mortality or major stroke H0: = πMCS TAVI ≥ 43.0% HA: = πMCS TAVI &lt; 43.0% In the above expressions πMCS TAVI denotes the rate of all-cause mortality or major stroke during a fixed follow-up of 1 year.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <method>z-test, 1 sided</method>
            <param_type>Kaplan-Meier</param_type>
            <param_value>26.0</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>2.0</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>22.3</ci_lower_limit>
            <ci_upper_limit>30.1</ci_upper_limit>
            <estimate_desc>Kaplan-Meier Event Rate Greenwood Standard Error</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>No performance goal created, only descriptive statistics are provided.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Kaplan-Meier</param_type>
            <param_value>39.3</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>4.0</dispersion_value>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>Kaplan-Meier Event Rate Greenwood Standard Error</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The 12 month all-cause mortality estimated rate was 20% for each group with a noninferiority margin of 7.5 percentage points. Assuming a 1:1 ratio in the treatment assignments, we estimated that a total of 355 patients were required in each group for the study to have power of 80% at a one-sided alpha level of 0.05. Accounting for a 10% loss to follow-up, we calculated that we would need to enroll 790 patients.</non_inferiority_desc>
            <p_value>&lt;0.0001</p_value>
            <method>z-test, 1 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Major Adverse Cardiovascular and Cerebrovascular Event (MACCE)</title>
        <description>MACCE is defined as a composite of:
All Cause Mortality
Myocardial infarction (MI)
All Stroke
Reintervention (defined as any cardiac surgery or percutaneous reintervention catheter procedure that repairs, otherwise alters or adjusts, or replaces a previously implanted valve)</description>
        <time_frame>30 day, 6 month, 1 year, 2 year</time_frame>
        <population>Participant Population= Consisted of all subjects with an attempted implant procedure.</population>
        <group_list>
          <group group_id="O1">
            <title>Extreme Risk: TAVI Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Iliofemoral Access</description>
          </group>
          <group group_id="O2">
            <title>Extreme Risk: TAVI Non-Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Non-Iliofemoral Access</description>
          </group>
          <group group_id="O3">
            <title>High Risk: TAVI</title>
            <description>High Risk Surgical Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O4">
            <title>High Risk: SAVR</title>
            <description>High Risk Surgical Patients: Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>Major Adverse Cardiovascular and Cerebrovascular Event (MACCE)</title>
          <description>MACCE is defined as a composite of:
All Cause Mortality
Myocardial infarction (MI)
All Stroke
Reintervention (defined as any cardiac surgery or percutaneous reintervention catheter procedure that repairs, otherwise alters or adjusts, or replaces a previously implanted valve)</description>
          <population>Participant Population= Consisted of all subjects with an attempted implant procedure.</population>
          <units>percentage of participants, Kaplan-Meier</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="489"/>
                <count group_id="O2" value="150"/>
                <count group_id="O3" value="391"/>
                <count group_id="O4" value="359"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>30 day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.3"/>
                    <measurement group_id="O2" value="17.3"/>
                    <measurement group_id="O3" value="7.7"/>
                    <measurement group_id="O4" value="10.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.5"/>
                    <measurement group_id="O2" value="34.7"/>
                    <measurement group_id="O3" value="15.4"/>
                    <measurement group_id="O4" value="21.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29.2"/>
                    <measurement group_id="O2" value="41.4"/>
                    <measurement group_id="O3" value="20.5"/>
                    <measurement group_id="O4" value="27.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 Year</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42.3"/>
                    <measurement group_id="O2" value="51.0"/>
                    <measurement group_id="O3" value="29.7"/>
                    <measurement group_id="O4" value="38.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Powered Secondary Hypothesis: TAVR with the Medtronic CoreValve System was superior to SAVR in binary rate of MACCE at 30 days or hospital discharge, whichever was longer:
H0: πMCS TAVR = πSAVR HA: πMCS TAVR &lt; πSAVR In the above expression πMCS TAVR and πSAVR denoted rates of MACCE at 30 days or hospital discharge, whichever was longer.
Assumptions:
1:1 treatment allocation ratio One-sided alpha=0.025 SAVR = 20.0% MCS TAVI = 12.1% Power = &gt;80%</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.1033</p_value>
            <p_value_desc>Hierarchical test item #5, MACCE at 30 days or hospital discharge; whichever was longer. K-M rates TAVR 8.21%, SAVR 10.93%, Difference -2.73%, Standard Error 2.16%, and Upper 95% CI 1.5%.</p_value_desc>
            <method>Kaplan-Meier Point Estimate</method>
            <method_desc>Using Greenwood formula</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Occurrence of Individual MACCE Components</title>
        <description>Individual MACCE Components Include:
All Cause Mortality
MI
All stroke
Reintervention (defined as any cardiac surgery or percutaneous reintervention catheter procedure that repairs, otherwise alters or adjusts, or replaces a previously implanted valve)</description>
        <time_frame>30 day, 6 month, 1 year, 2 year</time_frame>
        <population>Participant Population= Consisted of all subjects with an attempted implant procedure.</population>
        <group_list>
          <group group_id="O1">
            <title>Extreme Risk: TAVI Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Iliofemoral Access</description>
          </group>
          <group group_id="O2">
            <title>Extreme Risk: TAVI Non-Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Non-Iliofemoral Access</description>
          </group>
          <group group_id="O3">
            <title>High Risk: TAVI</title>
            <description>High Risk Surgical Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O4">
            <title>High Risk: SAVR</title>
            <description>High Risk Surgical Patients: Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>The Occurrence of Individual MACCE Components</title>
          <description>Individual MACCE Components Include:
All Cause Mortality
MI
All stroke
Reintervention (defined as any cardiac surgery or percutaneous reintervention catheter procedure that repairs, otherwise alters or adjusts, or replaces a previously implanted valve)</description>
          <population>Participant Population= Consisted of all subjects with an attempted implant procedure.</population>
          <units>percentage of participants, Kaplan-Meier</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="489"/>
                <count group_id="O2" value="150"/>
                <count group_id="O3" value="391"/>
                <count group_id="O4" value="359"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>30 day All Cause Mortality</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.4"/>
                    <measurement group_id="O2" value="11.3"/>
                    <measurement group_id="O3" value="3.3"/>
                    <measurement group_id="O4" value="4.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 day MI</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.2"/>
                    <measurement group_id="O2" value="2.1"/>
                    <measurement group_id="O3" value="0.8"/>
                    <measurement group_id="O4" value="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 day Stroke</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.0"/>
                    <measurement group_id="O2" value="8.8"/>
                    <measurement group_id="O3" value="4.9"/>
                    <measurement group_id="O4" value="6.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 day Reintervention</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.1"/>
                    <measurement group_id="O2" value="0.0"/>
                    <measurement group_id="O3" value="0.8"/>
                    <measurement group_id="O4" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month All Cause Mortality</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.6"/>
                    <measurement group_id="O2" value="28.7"/>
                    <measurement group_id="O3" value="9.0"/>
                    <measurement group_id="O4" value="14.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month MI</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.5"/>
                    <measurement group_id="O2" value="2.1"/>
                    <measurement group_id="O3" value="1.6"/>
                    <measurement group_id="O4" value="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month Stroke</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.2"/>
                    <measurement group_id="O2" value="12.0"/>
                    <measurement group_id="O3" value="7.3"/>
                    <measurement group_id="O4" value="9.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month Reintervention</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.5"/>
                    <measurement group_id="O2" value="0.0"/>
                    <measurement group_id="O3" value="1.0"/>
                    <measurement group_id="O4" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year All Cause Mortality</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24.3"/>
                    <measurement group_id="O2" value="36.0"/>
                    <measurement group_id="O3" value="14.1"/>
                    <measurement group_id="O4" value="18.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year MI</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.0"/>
                    <measurement group_id="O2" value="2.1"/>
                    <measurement group_id="O3" value="1.9"/>
                    <measurement group_id="O4" value="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year Stroke</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.0"/>
                    <measurement group_id="O2" value="13.0"/>
                    <measurement group_id="O3" value="8.7"/>
                    <measurement group_id="O4" value="12.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year Reintervention</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.8"/>
                    <measurement group_id="O2" value="1.0"/>
                    <measurement group_id="O3" value="2.2"/>
                    <measurement group_id="O4" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 year All Cause Mortality</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36.6"/>
                    <measurement group_id="O2" value="44.9"/>
                    <measurement group_id="O3" value="22.2"/>
                    <measurement group_id="O4" value="28.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 year MI</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.8"/>
                    <measurement group_id="O2" value="3.2"/>
                    <measurement group_id="O3" value="1.9"/>
                    <measurement group_id="O4" value="2.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 year Stroke</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.6"/>
                    <measurement group_id="O2" value="16.1"/>
                    <measurement group_id="O3" value="10.9"/>
                    <measurement group_id="O4" value="16.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 year Reintervention</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.8"/>
                    <measurement group_id="O2" value="1.0"/>
                    <measurement group_id="O3" value="2.5"/>
                    <measurement group_id="O4" value="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Major Adverse Events (MAEs)</title>
        <description>MAEs Include:
MACCE
Acute Kidney Injury
Cardiac Tamponade
Prosthetic Valve Dysfunction
Cardiogenic Shock
Valve Endocarditis
Life-Threatening, Disabling or Major Bleeding
Major Vascular Complication
Cardiac Perforation
Device Migration/Valve Embolism</description>
        <time_frame>30 day, 6 month, 1 year, 2 year</time_frame>
        <population>Participant Population= Consisted of all subjects with an attempted implant procedure.</population>
        <group_list>
          <group group_id="O1">
            <title>Extreme Risk: TAVI Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Iliofemoral Access</description>
          </group>
          <group group_id="O2">
            <title>Extreme Risk: TAVI Non-Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Non-Iliofemoral Access</description>
          </group>
          <group group_id="O3">
            <title>High Risk: TAVI</title>
            <description>High Risk Surgical Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O4">
            <title>High Risk: SAVR</title>
            <description>High Risk Surgical Patients: Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>Major Adverse Events (MAEs)</title>
          <description>MAEs Include:
MACCE
Acute Kidney Injury
Cardiac Tamponade
Prosthetic Valve Dysfunction
Cardiogenic Shock
Valve Endocarditis
Life-Threatening, Disabling or Major Bleeding
Major Vascular Complication
Cardiac Perforation
Device Migration/Valve Embolism</description>
          <population>Participant Population= Consisted of all subjects with an attempted implant procedure.</population>
          <units>percentage of participants, Kaplan-Meier</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="489"/>
                <count group_id="O2" value="150"/>
                <count group_id="O3" value="391"/>
                <count group_id="O4" value="359"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>30 day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54.2"/>
                    <measurement group_id="O2" value="69.3"/>
                    <measurement group_id="O3" value="52.4"/>
                    <measurement group_id="O4" value="50.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="60.5"/>
                    <measurement group_id="O2" value="76.0"/>
                    <measurement group_id="O3" value="58.6"/>
                    <measurement group_id="O4" value="76.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63.4"/>
                    <measurement group_id="O2" value="80.0"/>
                    <measurement group_id="O3" value="60.1"/>
                    <measurement group_id="O4" value="59.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 year</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="71.3"/>
                    <measurement group_id="O2" value="84.0"/>
                    <measurement group_id="O3" value="66.4"/>
                    <measurement group_id="O4" value="66.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Conduction Disturbance Requiring Permanent Pacemaker Implantation</title>
        <time_frame>30 day, 6 month, 1 year, 2 year</time_frame>
        <population>Participant Population= Consisted of all subjects with an attempted implant procedure.</population>
        <group_list>
          <group group_id="O1">
            <title>Extreme Risk: TAVI Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Iliofemoral Access</description>
          </group>
          <group group_id="O2">
            <title>Extreme Risk: TAVI Non-Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Non-Iliofemoral Access</description>
          </group>
          <group group_id="O3">
            <title>High Risk: TAVI</title>
            <description>High Risk Surgical Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O4">
            <title>High Risk: SAVR</title>
            <description>High Risk Surgical Patients: Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>Conduction Disturbance Requiring Permanent Pacemaker Implantation</title>
          <population>Participant Population= Consisted of all subjects with an attempted implant procedure.</population>
          <units>percentage of participants, Kaplan-Meier</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="489"/>
                <count group_id="O2" value="150"/>
                <count group_id="O3" value="391"/>
                <count group_id="O4" value="359"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>30 day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.6"/>
                    <measurement group_id="O2" value="16.4"/>
                    <measurement group_id="O3" value="20.0"/>
                    <measurement group_id="O4" value="7.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24.4"/>
                    <measurement group_id="O2" value="20.5"/>
                    <measurement group_id="O3" value="21.9"/>
                    <measurement group_id="O4" value="9.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.4"/>
                    <measurement group_id="O2" value="21.5"/>
                    <measurement group_id="O3" value="22.5"/>
                    <measurement group_id="O4" value="11.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 year</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.8"/>
                    <measurement group_id="O2" value="22.6"/>
                    <measurement group_id="O3" value="25.8"/>
                    <measurement group_id="O4" value="12.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in NYHA Class</title>
        <description>Change from baseline (continuous variable). A positive number corresponds to NYHA worsening; a negative number corresponds to NYHA improvement.
New York Heart Association (NYHA) Classification:
Class I: Subjects with cardiac disease but without resulting limitations of physical activity.
Class I: Subjects with cardiac disease resulting in slight limitation of physical activity.
Class III: Subjects with cardiac disease resulting in marked limitation of physical activity.
Class IV: Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort.</description>
        <time_frame>30 day, 6 month, 1 year, 2 year</time_frame>
        <population>Participant Population= Consisted of all subjects with an attempted implant procedure.</population>
        <group_list>
          <group group_id="O1">
            <title>Extreme Risk: TAVI Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Iliofemoral Access</description>
          </group>
          <group group_id="O2">
            <title>Extreme Risk: TAVI Non-Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Non-Iliofemoral Access</description>
          </group>
          <group group_id="O3">
            <title>High Risk: TAVI</title>
            <description>High Risk Surgical Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O4">
            <title>High Risk: SAVR</title>
            <description>High Risk Surgical Patients: Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>Change in NYHA Class</title>
          <description>Change from baseline (continuous variable). A positive number corresponds to NYHA worsening; a negative number corresponds to NYHA improvement.
New York Heart Association (NYHA) Classification:
Class I: Subjects with cardiac disease but without resulting limitations of physical activity.
Class I: Subjects with cardiac disease resulting in slight limitation of physical activity.
Class III: Subjects with cardiac disease resulting in marked limitation of physical activity.
Class IV: Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort.</description>
          <population>Participant Population= Consisted of all subjects with an attempted implant procedure.</population>
          <units>average classification level change</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="489"/>
                <count group_id="O2" value="150"/>
                <count group_id="O3" value="391"/>
                <count group_id="O4" value="359"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>30 day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.3" spread="0.9"/>
                    <measurement group_id="O2" value="-1.0" spread="0.8"/>
                    <measurement group_id="O3" value="-1.3" spread="0.8"/>
                    <measurement group_id="O4" value="-1.0" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.6" spread="0.9"/>
                    <measurement group_id="O2" value="-1.4" spread="0.8"/>
                    <measurement group_id="O3" value="-1.5" spread="0.8"/>
                    <measurement group_id="O4" value="-1.4" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.6" spread="0.9"/>
                    <measurement group_id="O2" value="-1.4" spread="0.8"/>
                    <measurement group_id="O3" value="-1.5" spread="0.8"/>
                    <measurement group_id="O4" value="-1.5" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 year</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.6" spread="0.8"/>
                    <measurement group_id="O2" value="-1.4" spread="0.7"/>
                    <measurement group_id="O3" value="-1.5" spread="0.8"/>
                    <measurement group_id="O4" value="-1.5" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Change in NYHA classification from baseline to 1 year from secondary objective #5. The paired t-test will be used to test the null hypothesis that the mean paired difference is zero versus the two-sided alternative that the mean is not zero.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>Hierarchical test item #3, change from baseline to 1 year.</p_value_desc>
            <method>t-test, 2 sided</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-1.6</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>0.9</dispersion_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Change in NYHA classification from baseline to 1 year: TAVR vs. SAVR from secondary objective #5. The one-sided two-sample t-test was used to test non-inferiority at a level 0.05 the hypotheses:
H0: µ MCS TAVR ≤ µ SAVR -0.375 HA: µ MCS TAVR &gt; µ SAVR -0.375 In the above expression µ MCS TAVR and µ SAVR denoted the mean number of classification improvements in NYHA from baseline to 1 year.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority margin= 0.375. For subjects with NYHA categories at both baseline and 1 year visit, the NYHA classification improvements were calculated as NYHAbaseline – NYHA1year.</non_inferiority_desc>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>Hierarchical test item #3, change from baseline to 1 year.</p_value_desc>
            <method>t-test, 1 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Distance Walked During 6-Minute Walk Test (6MWT)</title>
        <description>Change in distance walked during 6MWT from baseline</description>
        <time_frame>30 day, 1 year</time_frame>
        <population>Participant Population= Consisted of all subjects with an attempted implant procedure.</population>
        <group_list>
          <group group_id="O1">
            <title>Extreme Risk: TAVI Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Iliofemoral Access</description>
          </group>
          <group group_id="O2">
            <title>Extreme Risk: TAVI Non-Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Non-Iliofemoral Access</description>
          </group>
          <group group_id="O3">
            <title>High Risk: TAVI</title>
            <description>High Risk Surgical Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O4">
            <title>High Risk: SAVR</title>
            <description>High Risk Surgical Patients: Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Distance Walked During 6-Minute Walk Test (6MWT)</title>
          <description>Change in distance walked during 6MWT from baseline</description>
          <population>Participant Population= Consisted of all subjects with an attempted implant procedure.</population>
          <units>meters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="489"/>
                <count group_id="O2" value="150"/>
                <count group_id="O3" value="391"/>
                <count group_id="O4" value="359"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>30 day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19.6" spread="109.1"/>
                    <measurement group_id="O2" value="13.3" spread="110.0"/>
                    <measurement group_id="O3" value="25.8" spread="105.5"/>
                    <measurement group_id="O4" value="-6.9" spread="89.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.9" spread="140.4"/>
                    <measurement group_id="O2" value="22.2" spread="136.2"/>
                    <measurement group_id="O3" value="27.0" spread="114.3"/>
                    <measurement group_id="O4" value="24.0" spread="111.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Ratio of Days Alive Out of Hospital Versus Total Days Alive</title>
        <time_frame>1 year</time_frame>
        <population>Participant Population= Consisted of all subjects with an attempted implant procedure.</population>
        <group_list>
          <group group_id="O1">
            <title>Extreme Risk: TAVI Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Iliofemoral Access</description>
          </group>
          <group group_id="O2">
            <title>Extreme Risk: TAVI Non-Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Non-Iliofemoral Access</description>
          </group>
          <group group_id="O3">
            <title>High Risk: TAVI</title>
            <description>High Risk Surgical Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O4">
            <title>High Risk: SAVR</title>
            <description>High Risk Surgical Patients: Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>Ratio of Days Alive Out of Hospital Versus Total Days Alive</title>
          <population>Participant Population= Consisted of all subjects with an attempted implant procedure.</population>
          <units>ratio of days alive and out of hospital</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="489"/>
                <count group_id="O2" value="150"/>
                <count group_id="O3" value="391"/>
                <count group_id="O4" value="359"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.86" spread="0.28"/>
                    <measurement group_id="O2" value="0.81" spread="0.31"/>
                    <measurement group_id="O3" value="0.92" spread="0.20"/>
                    <measurement group_id="O4" value="0.89" spread="0.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Quality of Life (QoL) Change</title>
        <description>QoL summary score change from baseline using the following measures:
Kansas City Cardiomyopathy Questionnaire (KCCQ): Quantifies physical function, symptoms, social function, self-efficacy and knowledge, and quality of life. Scores are transformed to a range of 0-100, in which higher scores reflect better health status.
12 Item Short Form Health Survey (SF-12): Measures functional health and well-being. Scores are transformed to a range of 0-100, in which higher scores reflect better health status.
European QoL (EQ-5D): Measures 5 domains (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) that can be converted to utilities using an algorithm. Utilities range from 0 to 1, with 1 representing perfect health, and 0 corresponding to the worst imaginable health state.</description>
        <time_frame>30 day, 6 month, 1 year, 2 year</time_frame>
        <population>Participant Population= Consisted of all subjects with an attempted implant procedure.</population>
        <group_list>
          <group group_id="O1">
            <title>Extreme Risk: TAVI Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Iliofemoral Access</description>
          </group>
          <group group_id="O2">
            <title>Extreme Risk: TAVI Non-Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Non-Iliofemoral Access</description>
          </group>
          <group group_id="O3">
            <title>High Risk: TAVI</title>
            <description>High Risk Surgical Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O4">
            <title>High Risk: SAVR</title>
            <description>High Risk Surgical Patients: Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>Quality of Life (QoL) Change</title>
          <description>QoL summary score change from baseline using the following measures:
Kansas City Cardiomyopathy Questionnaire (KCCQ): Quantifies physical function, symptoms, social function, self-efficacy and knowledge, and quality of life. Scores are transformed to a range of 0-100, in which higher scores reflect better health status.
12 Item Short Form Health Survey (SF-12): Measures functional health and well-being. Scores are transformed to a range of 0-100, in which higher scores reflect better health status.
European QoL (EQ-5D): Measures 5 domains (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) that can be converted to utilities using an algorithm. Utilities range from 0 to 1, with 1 representing perfect health, and 0 corresponding to the worst imaginable health state.</description>
          <population>Participant Population= Consisted of all subjects with an attempted implant procedure.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="489"/>
                <count group_id="O2" value="150"/>
                <count group_id="O3" value="391"/>
                <count group_id="O4" value="359"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>30 day KCCQ- Overall</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24.2" spread="28.9"/>
                    <measurement group_id="O2" value="7.9" spread="33.5"/>
                    <measurement group_id="O3" value="19.0" spread="29.4"/>
                    <measurement group_id="O4" value="4.3" spread="28.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 day KCCQ- Clinical</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.2" spread="28.0"/>
                    <measurement group_id="O2" value="6.8" spread="32.0"/>
                    <measurement group_id="O3" value="14.7" spread="28.6"/>
                    <measurement group_id="O4" value="2.7" spread="27.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 day SF-12-Physical</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.9" spread="10.4"/>
                    <measurement group_id="O2" value="1.9" spread="10.4"/>
                    <measurement group_id="O3" value="4.9" spread="10.2"/>
                    <measurement group_id="O4" value="-0.0" spread="10.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 day SF-12-Mental</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.7" spread="14.2"/>
                    <measurement group_id="O2" value="-1.7" spread="16.2"/>
                    <measurement group_id="O3" value="2.6" spread="13.1"/>
                    <measurement group_id="O4" value="-2.5" spread="13.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 day EQ-5D</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.09" spread="0.29"/>
                    <measurement group_id="O2" value="0.00" spread="0.30"/>
                    <measurement group_id="O3" value="0.04" spread="0.24"/>
                    <measurement group_id="O4" value="-0.07" spread="0.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month KCCQ-Overall</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27.4" spread="27.0"/>
                    <measurement group_id="O2" value="23.1" spread="28.3"/>
                    <measurement group_id="O3" value="24.8" spread="26.9"/>
                    <measurement group_id="O4" value="22.9" spread="26.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month KCCQ- Clinical</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.2" spread="26.1"/>
                    <measurement group_id="O2" value="17.5" spread="26.6"/>
                    <measurement group_id="O3" value="18.6" spread="25.7"/>
                    <measurement group_id="O4" value="17.7" spread="25.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month SF-12-Physical</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.2" spread="11.3"/>
                    <measurement group_id="O2" value="4.5" spread="8.9"/>
                    <measurement group_id="O3" value="6.3" spread="11.0"/>
                    <measurement group_id="O4" value="6.2" spread="9.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month SF-12-Mental</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.6" spread="13.6"/>
                    <measurement group_id="O2" value="4.4" spread="13.8"/>
                    <measurement group_id="O3" value="4.6" spread="11.8"/>
                    <measurement group_id="O4" value="2.6" spread="13.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month EQ-5D</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.09" spread="0.22"/>
                    <measurement group_id="O2" value="0.05" spread="0.21"/>
                    <measurement group_id="O3" value="0.05" spread="0.22"/>
                    <measurement group_id="O4" value="0.04" spread="0.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year KCCQ-Overall</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27.9" spread="27.1"/>
                    <measurement group_id="O2" value="21.9" spread="26.8"/>
                    <measurement group_id="O3" value="23.2" spread="25.4"/>
                    <measurement group_id="O4" value="21.8" spread="26.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year KCCQ- Clinical</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.8" spread="26.8"/>
                    <measurement group_id="O2" value="18.1" spread="24.9"/>
                    <measurement group_id="O3" value="16.7" spread="25.5"/>
                    <measurement group_id="O4" value="15.2" spread="26.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year SF-12-Physical</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.5" spread="10.8"/>
                    <measurement group_id="O2" value="4.6" spread="10.0"/>
                    <measurement group_id="O3" value="6.0" spread="11.5"/>
                    <measurement group_id="O4" value="5.3" spread="10.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year SF-12-Mental</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.2" spread="13.7"/>
                    <measurement group_id="O2" value="2.4" spread="14.3"/>
                    <measurement group_id="O3" value="4.5" spread="11.8"/>
                    <measurement group_id="O4" value="3.2" spread="12.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year EQ-5D</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.06" spread="0.25"/>
                    <measurement group_id="O2" value="0.05" spread="0.25"/>
                    <measurement group_id="O3" value="0.04" spread="0.19"/>
                    <measurement group_id="O4" value="0.01" spread="0.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 year KCCQ - Overall</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25.2" spread="27.2"/>
                    <measurement group_id="O2" value="14.9" spread="29.5"/>
                    <measurement group_id="O3" value="22.2" spread="26.5"/>
                    <measurement group_id="O4" value="18.7" spread="25.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 year KCCQ - Clinical</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.8" spread="26.1"/>
                    <measurement group_id="O2" value="11.6" spread="26.9"/>
                    <measurement group_id="O3" value="14.6" spread="26.0"/>
                    <measurement group_id="O4" value="12.6" spread="25.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 year SF-12 - Physical</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.0" spread="11.2"/>
                    <measurement group_id="O2" value="1.9" spread="11.9"/>
                    <measurement group_id="O3" value="5.0" spread="12.1"/>
                    <measurement group_id="O4" value="4.3" spread="10.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 year SF-12 - Mental</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.8" spread="15.3"/>
                    <measurement group_id="O2" value="2.2" spread="14.8"/>
                    <measurement group_id="O3" value="3.6" spread="13.0"/>
                    <measurement group_id="O4" value="1.7" spread="13.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 year EQ-5D</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.04" spread="0.25"/>
                    <measurement group_id="O2" value="0.03" spread="0.26"/>
                    <measurement group_id="O3" value="-0.01" spread="0.24"/>
                    <measurement group_id="O4" value="-0.01" spread="0.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Change in Kansas City Cardiomyopathy Questionnaire (KCCQ) score from baseline to 1 year from secondary objective #8. The paired t-test will be used to test the null hypothesis that the mean paired difference is zero versus the two-sided alternative that the mean is not zero.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>Hierarchical test item #4</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Change in Kansas City Cardiomyopathy Questionnaire (KCCQ) score from baseline to 1 year: TAVR vs. SAVR from secondary objective #8. The one-sided two-sample t-test was used to test non-inferiority at a level 0.05 the hypotheses:
H0: µ MCS TAVR ≤ µ SAVR -5 HA: µ MCS TAVR &gt; µ SAVR -5 In the above expression µ MCS TAVR and µ SAVR denoted the mean improvements in the KCCQ score from baseline to 1 year.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority margin 5</non_inferiority_desc>
            <p_value>0.0063</p_value>
            <p_value_desc>Hierarchical test item #4</p_value_desc>
            <method>t-test, 1 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Change in SF-12 Physical Summary Scale from baseline to 30 days: TAVR vs. SAVR from secondary objective #8. The two-sided two-sample t-test was used to test at a level 0.05 the hypotheses:
H0: µ MCS TAVR = µ SAVR HA: µ MCS TAVR ≠ µ SAVR In the above expression µ MCS TAVR and µ SAVR denoted the mean improvements in the SF-12 Physical Summary Scale from baseline to 30 days.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>Hierarchical test item #6. Item #5 failed, therefore, item #6 also fails. Nominal p- value provided.</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Echocardiographic Assessment of Valve Performance</title>
        <description>Using the following measures:
- Effective Orifice Area (EOA)</description>
        <time_frame>30 day, 6 month, 1 year, 2 year</time_frame>
        <population>Participant Population= Consisted of all subjects with a valve implanted.</population>
        <group_list>
          <group group_id="O1">
            <title>Extreme Risk: TAVI Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Iliofemoral Access</description>
          </group>
          <group group_id="O2">
            <title>Extreme Risk: TAVI Non-Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Non-Iliofemoral Access</description>
          </group>
          <group group_id="O3">
            <title>High Risk: TAVI</title>
            <description>High Risk Surgical Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O4">
            <title>High Risk: SAVR</title>
            <description>High Risk Surgical Patients: Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>Echocardiographic Assessment of Valve Performance</title>
          <description>Using the following measures:
- Effective Orifice Area (EOA)</description>
          <population>Participant Population= Consisted of all subjects with a valve implanted.</population>
          <units>cm^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="486"/>
                <count group_id="O2" value="148"/>
                <count group_id="O3" value="390"/>
                <count group_id="O4" value="354"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>30 day EOA</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.86" spread="0.56"/>
                    <measurement group_id="O2" value="1.82" spread="0.64"/>
                    <measurement group_id="O3" value="1.94" spread="0.56"/>
                    <measurement group_id="O4" value="1.60" spread="0.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month EOA</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.88" spread="0.55"/>
                    <measurement group_id="O2" value="1.85" spread="0.51"/>
                    <measurement group_id="O3" value="1.91" spread="0.53"/>
                    <measurement group_id="O4" value="1.56" spread="0.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year EOA</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.88" spread="0.54"/>
                    <measurement group_id="O2" value="1.85" spread="0.51"/>
                    <measurement group_id="O3" value="1.91" spread="0.52"/>
                    <measurement group_id="O4" value="1.57" spread="0.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 year EOA</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.86" spread="0.55"/>
                    <measurement group_id="O2" value="1.83" spread="0.58"/>
                    <measurement group_id="O3" value="1.87" spread="0.48"/>
                    <measurement group_id="O4" value="1.51" spread="0.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>EOA:
Change in effective orifice area from Baseline to 1 year from secondary objective #9. The paired t-test will be used to test the null hypothesis that the mean paired difference is zero versus the two-sided alternative that the mean is not zero.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>Hierarchical test item #2</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>EOA:
Change in effective orifice area from Baseline to 1 year: TAVR vs.SAVR from secondary objective #9. The one-sided two-sample t-test was used to test non-inferiority at a level 0.05 the hypotheses:
H0: µ MCS TAVR ≤ µ SAVR -0.375 HA: µ MCS TAVR &gt; µ SAVR -0.375 In the above expression µ MCS TAVR and µ SAVR denoted the mean improvements in effective orifice area from Baseline to 1 year measured in cm2.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority margin 0.375</non_inferiority_desc>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>Hierarchical test item #2</p_value_desc>
            <method>t-test, 1 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Echocardiographic Assessment of Valve Performance</title>
        <description>Using the following measures:
- Transvalvular Mean Gradient</description>
        <time_frame>30 day, 6 month, 1 year, 2 year</time_frame>
        <population>Participant Population= Consisted of all subjects with a valve implanted.</population>
        <group_list>
          <group group_id="O1">
            <title>Extreme Risk: TAVI Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Iliofemoral Access</description>
          </group>
          <group group_id="O2">
            <title>Extreme Risk: TAVI Non-Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Non-Iliofemoral Access</description>
          </group>
          <group group_id="O3">
            <title>High Risk: TAVI</title>
            <description>High Risk Surgical Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O4">
            <title>High Risk: SAVR</title>
            <description>High Risk Surgical Patients: Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>Echocardiographic Assessment of Valve Performance</title>
          <description>Using the following measures:
- Transvalvular Mean Gradient</description>
          <population>Participant Population= Consisted of all subjects with a valve implanted.</population>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="486"/>
                <count group_id="O2" value="148"/>
                <count group_id="O3" value="390"/>
                <count group_id="O4" value="354"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>30 day Mean Gradient</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.68" spread="4.16"/>
                    <measurement group_id="O2" value="9.74" spread="5.82"/>
                    <measurement group_id="O3" value="8.88" spread="3.86"/>
                    <measurement group_id="O4" value="11.72" spread="5.70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month Mean Gradient</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.10" spread="3.89"/>
                    <measurement group_id="O2" value="9.42" spread="5.60"/>
                    <measurement group_id="O3" value="9.08" spread="4.08"/>
                    <measurement group_id="O4" value="12.12" spread="6.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year Mean Gradient</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.86" spread="4.09"/>
                    <measurement group_id="O2" value="9.46" spread="5.65"/>
                    <measurement group_id="O3" value="9.09" spread="3.49"/>
                    <measurement group_id="O4" value="12.44" spread="7.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 year Mean Gradient</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.70" spread="4.22"/>
                    <measurement group_id="O2" value="9.24" spread="5.35"/>
                    <measurement group_id="O3" value="8.47" spread="3.76"/>
                    <measurement group_id="O4" value="12.05" spread="6.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Transvalvular Mean Gradient:
Change in transvalvular mean gradient from baseline to 1 year from secondary objective #9. The paired t-test will be used to test the null hypothesis that the mean paired difference is zero versus the two-sided alternative that the mean is not zero.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>Hierarchical test item #1</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Transvalvular Mean Gradient:
Change in transvalvular mean gradient from baseline to 1 year: TAVR vs.SAVR from secondary objective #9. The one-sided two-sample t-test was used to test non-inferiority at a level of 0.05 the hypotheses: H0: μ MCS TAVR ≤ μ SAVR -15 HA: μ MCS TAVR &gt; μ SAVR -15 In the above expression μ MCS TAVR and μ SAVR denoted the mean improvements in mean gradient from Baseline to 1 year measured in mmHg.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority margin 15</non_inferiority_desc>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>Hierarchical test item #1</p_value_desc>
            <method>t-test, 1 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Echocardiographic Assessment of Valve Performance</title>
        <description>Using the following measure:
- Degree of Aortic Valve Regurgitation (Transvalvular and Paravalvular)</description>
        <time_frame>30 day, 6 month, 1 year, 2 year</time_frame>
        <population>Participant Population= Consisted of all subjects with a valve implanted.</population>
        <group_list>
          <group group_id="O1">
            <title>Extreme Risk: TAVI Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Iliofemoral Access</description>
          </group>
          <group group_id="O2">
            <title>Extreme Risk: TAVI Non-Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Non-Iliofemoral Access</description>
          </group>
          <group group_id="O3">
            <title>High Risk: TAVI</title>
            <description>High Risk Surgical Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O4">
            <title>High Risk: SAVR</title>
            <description>High Risk Surgical Patients: Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>Echocardiographic Assessment of Valve Performance</title>
          <description>Using the following measure:
- Degree of Aortic Valve Regurgitation (Transvalvular and Paravalvular)</description>
          <population>Participant Population= Consisted of all subjects with a valve implanted.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="486"/>
                <count group_id="O2" value="148"/>
                <count group_id="O3" value="390"/>
                <count group_id="O4" value="354"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>30 day Total Aortic Regurgitation- None</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.1"/>
                    <measurement group_id="O2" value="19.0"/>
                    <measurement group_id="O3" value="12.2"/>
                    <measurement group_id="O4" value="65.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 day Total Aortic Regurgitation- Trivial</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32.7"/>
                    <measurement group_id="O2" value="33.9"/>
                    <measurement group_id="O3" value="41.4"/>
                    <measurement group_id="O4" value="23.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 day Total Aortic Regurgitation- Mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43.0"/>
                    <measurement group_id="O2" value="34.7"/>
                    <measurement group_id="O3" value="36.4"/>
                    <measurement group_id="O4" value="10.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 day Total Aortic Regurgitation- Moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.1"/>
                    <measurement group_id="O2" value="10.7"/>
                    <measurement group_id="O3" value="8.1"/>
                    <measurement group_id="O4" value="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 day Total Aortic Regurgitation- Severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.2"/>
                    <measurement group_id="O2" value="1.7"/>
                    <measurement group_id="O3" value="1.9"/>
                    <measurement group_id="O4" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month Total Aortic Regurgitation- None</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19.9"/>
                    <measurement group_id="O2" value="33.3"/>
                    <measurement group_id="O3" value="21.6"/>
                    <measurement group_id="O4" value="60.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month Total Aortic Regurgitation- Trivial</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33.5"/>
                    <measurement group_id="O2" value="27.1"/>
                    <measurement group_id="O3" value="37.2"/>
                    <measurement group_id="O4" value="28.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month Total Aortic Regurgitation- Mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36.5"/>
                    <measurement group_id="O2" value="35.4"/>
                    <measurement group_id="O3" value="29.7"/>
                    <measurement group_id="O4" value="9.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month Total Aortic Regurgitation- Moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.8"/>
                    <measurement group_id="O2" value="4.2"/>
                    <measurement group_id="O3" value="10.0"/>
                    <measurement group_id="O4" value="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month Total Aortic Regurgitation- Severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.3"/>
                    <measurement group_id="O2" value="0.0"/>
                    <measurement group_id="O3" value="1.6"/>
                    <measurement group_id="O4" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year Total Aortic Regurgitation- None</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.5"/>
                    <measurement group_id="O2" value="39.0"/>
                    <measurement group_id="O3" value="28.3"/>
                    <measurement group_id="O4" value="68.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year Total Aortic Regurgitation- Trivial</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40.6"/>
                    <measurement group_id="O2" value="36.6"/>
                    <measurement group_id="O3" value="35.7"/>
                    <measurement group_id="O4" value="21.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year Total Aortic Regurgitation- Mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31.5"/>
                    <measurement group_id="O2" value="20.7"/>
                    <measurement group_id="O3" value="29.0"/>
                    <measurement group_id="O4" value="8.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year Total Aortic Regurgitation- Moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.4"/>
                    <measurement group_id="O2" value="2.4"/>
                    <measurement group_id="O3" value="6.7"/>
                    <measurement group_id="O4" value="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year Total Aortic Regurgitation- Severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                    <measurement group_id="O2" value="1.2"/>
                    <measurement group_id="O3" value="0.3"/>
                    <measurement group_id="O4" value="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 year Total Aortic Regurgitation - None</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31.0"/>
                    <measurement group_id="O2" value="35.3"/>
                    <measurement group_id="O3" value="32.8"/>
                    <measurement group_id="O4" value="58.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 year Total Aortic Regurgitation - Trivial</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.3"/>
                    <measurement group_id="O2" value="36.8"/>
                    <measurement group_id="O3" value="27.0"/>
                    <measurement group_id="O4" value="27.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 year Total Aortic Regurgitation - Mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36.1"/>
                    <measurement group_id="O2" value="23.5"/>
                    <measurement group_id="O3" value="32.0"/>
                    <measurement group_id="O4" value="13.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 year Total Aortic Regurgitation - Moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.7"/>
                    <measurement group_id="O2" value="4.4"/>
                    <measurement group_id="O3" value="6.6"/>
                    <measurement group_id="O4" value="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 year Total Aortic Regurgitation - Severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                    <measurement group_id="O2" value="0.0"/>
                    <measurement group_id="O3" value="1.6"/>
                    <measurement group_id="O4" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Aortic Valve Hospitalizations</title>
        <time_frame>30 day, 6 month, 1 year, 2 year</time_frame>
        <population>Participant Population= Consisted of all subjects with an attempted implant procedure</population>
        <group_list>
          <group group_id="O1">
            <title>Extreme Risk: TAVI Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Iliofemoral Access</description>
          </group>
          <group group_id="O2">
            <title>Extreme Risk: TAVI Non-Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Non-Iliofemoral Access</description>
          </group>
          <group group_id="O3">
            <title>High Risk: TAVI</title>
            <description>High Risk Surgical Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O4">
            <title>High Risk: SAVR</title>
            <description>High Risk Surgical Patients: Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>Aortic Valve Hospitalizations</title>
          <population>Participant Population= Consisted of all subjects with an attempted implant procedure</population>
          <units>percentage of participants, Kaplan-Meier</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="489"/>
                <count group_id="O2" value="150"/>
                <count group_id="O3" value="391"/>
                <count group_id="O4" value="359"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>30 day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.7"/>
                    <measurement group_id="O2" value="8.7"/>
                    <measurement group_id="O3" value="3.9"/>
                    <measurement group_id="O4" value="5.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.4"/>
                    <measurement group_id="O2" value="18.3"/>
                    <measurement group_id="O3" value="13.4"/>
                    <measurement group_id="O4" value="9.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.9"/>
                    <measurement group_id="O2" value="21.2"/>
                    <measurement group_id="O3" value="16.5"/>
                    <measurement group_id="O4" value="14.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 year</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29.5"/>
                    <measurement group_id="O2" value="27.2"/>
                    <measurement group_id="O3" value="24.2"/>
                    <measurement group_id="O4" value="18.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cardiovascular Deaths and Valve Related Deaths</title>
        <time_frame>30 day, 6 month, 1 year, 2 year</time_frame>
        <population>Participant Population= Consisted of all subjects with an attempted implant procedure.</population>
        <group_list>
          <group group_id="O1">
            <title>Extreme Risk: TAVI Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Iliofemoral Access</description>
          </group>
          <group group_id="O2">
            <title>Extreme Risk: TAVI Non-Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Non-Iliofemoral Access</description>
          </group>
          <group group_id="O3">
            <title>High Risk: TAVI</title>
            <description>High Risk Surgical Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O4">
            <title>High Risk: SAVR</title>
            <description>High Risk Surgical Patients: Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>Cardiovascular Deaths and Valve Related Deaths</title>
          <population>Participant Population= Consisted of all subjects with an attempted implant procedure.</population>
          <units>percentage of participants, Kaplan-Meier</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="489"/>
                <count group_id="O2" value="150"/>
                <count group_id="O3" value="391"/>
                <count group_id="O4" value="359"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>30 day Cardiovascular Deaths</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.4"/>
                    <measurement group_id="O2" value="11.3"/>
                    <measurement group_id="O3" value="3.3"/>
                    <measurement group_id="O4" value="4.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 Day Valve Related Deaths</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.5"/>
                    <measurement group_id="O2" value="2.8"/>
                    <measurement group_id="O3" value="2.3"/>
                    <measurement group_id="O4" value="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month Cardiovascular Deaths</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.0"/>
                    <measurement group_id="O2" value="23.6"/>
                    <measurement group_id="O3" value="7.4"/>
                    <measurement group_id="O4" value="10.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month Valve Related Deaths</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.1"/>
                    <measurement group_id="O2" value="4.5"/>
                    <measurement group_id="O3" value="3.6"/>
                    <measurement group_id="O4" value="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year Cardiovascular Deaths</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.3"/>
                    <measurement group_id="O2" value="28.7"/>
                    <measurement group_id="O3" value="10.6"/>
                    <measurement group_id="O4" value="12.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year Valve Related Deaths</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.1"/>
                    <measurement group_id="O2" value="5.4"/>
                    <measurement group_id="O3" value="5.6"/>
                    <measurement group_id="O4" value="2.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 year Cardiovascular Deaths</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.2"/>
                    <measurement group_id="O2" value="35.1"/>
                    <measurement group_id="O3" value="15.4"/>
                    <measurement group_id="O4" value="19.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 year Valve Related Deaths</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.2"/>
                    <measurement group_id="O2" value="7.5"/>
                    <measurement group_id="O3" value="6.8"/>
                    <measurement group_id="O4" value="4.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Strokes and Transient Ischemic Attacks (TIAs)</title>
        <description>Strokes (of any severity) and TIAs</description>
        <time_frame>30 day, 6 month, 1 year, 2 year</time_frame>
        <population>Participant Population= Consisted of all subjects with an attempted implant procedure.</population>
        <group_list>
          <group group_id="O1">
            <title>Extreme Risk: TAVI Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Iliofemoral Access</description>
          </group>
          <group group_id="O2">
            <title>Extreme Risk: TAVI Non-Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Non-Iliofemoral Access</description>
          </group>
          <group group_id="O3">
            <title>High Risk: TAVI</title>
            <description>High Risk Surgical Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O4">
            <title>High Risk: SAVR</title>
            <description>High Risk Surgical Patients: Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>Strokes and Transient Ischemic Attacks (TIAs)</title>
          <description>Strokes (of any severity) and TIAs</description>
          <population>Participant Population= Consisted of all subjects with an attempted implant procedure.</population>
          <units>percentage of participants, Kaplan-Meier</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="489"/>
                <count group_id="O2" value="150"/>
                <count group_id="O3" value="391"/>
                <count group_id="O4" value="359"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>30 day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.6"/>
                    <measurement group_id="O2" value="10.2"/>
                    <measurement group_id="O3" value="5.7"/>
                    <measurement group_id="O4" value="6.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.0"/>
                    <measurement group_id="O2" value="14.3"/>
                    <measurement group_id="O3" value="8.4"/>
                    <measurement group_id="O4" value="10.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.1"/>
                    <measurement group_id="O2" value="15.2"/>
                    <measurement group_id="O3" value="10.3"/>
                    <measurement group_id="O4" value="14.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 year</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.1"/>
                    <measurement group_id="O2" value="19.5"/>
                    <measurement group_id="O3" value="13.2"/>
                    <measurement group_id="O4" value="17.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Index Procedure Related MAEs</title>
        <time_frame>Procedure</time_frame>
        <population>Participant Population= Consisted of all subjects with an attempted implant procedure.</population>
        <group_list>
          <group group_id="O1">
            <title>Extreme Risk: TAVI Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Iliofemoral Access</description>
          </group>
          <group group_id="O2">
            <title>Extreme Risk: TAVI Non-Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Non-Iliofemoral Access</description>
          </group>
          <group group_id="O3">
            <title>High Risk: TAVI</title>
            <description>High Risk Surgical Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O4">
            <title>High Risk: SAVR</title>
            <description>High Risk Surgical Patients: Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>Index Procedure Related MAEs</title>
          <population>Participant Population= Consisted of all subjects with an attempted implant procedure.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="489"/>
                <count group_id="O2" value="150"/>
                <count group_id="O3" value="391"/>
                <count group_id="O4" value="359"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53.5"/>
                    <measurement group_id="O2" value="68.9"/>
                    <measurement group_id="O3" value="52.6"/>
                    <measurement group_id="O4" value="49.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Length of Index Procedure Hospital Stay</title>
        <time_frame>Number of days from admission to discharge</time_frame>
        <population>Participant Population= Consisted of all subjects with an attempted implant procedure.</population>
        <group_list>
          <group group_id="O1">
            <title>Extreme Risk: TAVI Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Iliofemoral Access</description>
          </group>
          <group group_id="O2">
            <title>Extreme Risk: TAVI Non-Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Non-Iliofemoral Access</description>
          </group>
          <group group_id="O3">
            <title>High Risk: TAVI</title>
            <description>High Risk Surgical Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O4">
            <title>High Risk: SAVR</title>
            <description>High Risk Surgical Patients: Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>Length of Index Procedure Hospital Stay</title>
          <population>Participant Population= Consisted of all subjects with an attempted implant procedure.</population>
          <units>days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="489"/>
                <count group_id="O2" value="150"/>
                <count group_id="O3" value="391"/>
                <count group_id="O4" value="359"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.2" spread="8.1"/>
                    <measurement group_id="O2" value="11.2" spread="8.9"/>
                    <measurement group_id="O3" value="8.0" spread="6.8"/>
                    <measurement group_id="O4" value="12.5" spread="10.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Device Success</title>
        <description>Medtronic CoreValve® System subjects only.
Defined as:
Successful vascular access, delivery and deployment of the device, and successful retrieval of the delivery system,
Correct position of the device in the proper anatomical location (placement in the annulus with no impedance on device function),
Intended performance of the prosthetic valve (aortic valve area &gt; 1.2 cm2 for 26, 29 and 31mm valves, ≥ 0.9 cm2 for 23mm valve (by echocardiography using the continuity equation) and mean aortic valve gradient &lt; 20 mmHg or peak velocity &lt; 3 m/sec, without moderate or severe prosthetic valve aortic regurgitation)
Only one valve implanted in the proper anatomical location</description>
        <time_frame>Number of days from admission to discharge</time_frame>
        <population>Participant Population= Consisted of all subjects with a TAVR index procedure who were evaluable for device success.</population>
        <group_list>
          <group group_id="O1">
            <title>Extreme Risk: TAVI Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Iliofemoral Access</description>
          </group>
          <group group_id="O2">
            <title>Extreme Risk: TAVI Non-Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Non-Iliofemoral Access</description>
          </group>
          <group group_id="O3">
            <title>High Risk: TAVI</title>
            <description>High Risk Surgical Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O4">
            <title>High Risk: SAVR</title>
            <description>High Risk Surgical Patients: Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>Device Success</title>
          <description>Medtronic CoreValve® System subjects only.
Defined as:
Successful vascular access, delivery and deployment of the device, and successful retrieval of the delivery system,
Correct position of the device in the proper anatomical location (placement in the annulus with no impedance on device function),
Intended performance of the prosthetic valve (aortic valve area &gt; 1.2 cm2 for 26, 29 and 31mm valves, ≥ 0.9 cm2 for 23mm valve (by echocardiography using the continuity equation) and mean aortic valve gradient &lt; 20 mmHg or peak velocity &lt; 3 m/sec, without moderate or severe prosthetic valve aortic regurgitation)
Only one valve implanted in the proper anatomical location</description>
          <population>Participant Population= Consisted of all subjects with a TAVR index procedure who were evaluable for device success.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="468"/>
                <count group_id="O2" value="141"/>
                <count group_id="O3" value="378"/>
                <count group_id="O4" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84.6"/>
                    <measurement group_id="O2" value="88.7"/>
                    <measurement group_id="O3" value="86.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Procedural Success</title>
        <description>Medtronic CoreValve® System subjects only.
Defined as device success and absence of in-hospital MACCE.</description>
        <time_frame>Number of days from admission to discharge</time_frame>
        <population>Participant Population= Consisted of all subjects with a TAVR index procedure who were evaluable for procedural success.</population>
        <group_list>
          <group group_id="O1">
            <title>Extreme Risk: TAVI Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Iliofemoral Access</description>
          </group>
          <group group_id="O2">
            <title>Extreme Risk: TAVI Non-Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Non-Iliofemoral Access</description>
          </group>
          <group group_id="O3">
            <title>High Risk: TAVI</title>
            <description>High Risk Surgical Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O4">
            <title>High Risk: SAVR</title>
            <description>High Risk Surgical Patients: Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>Procedural Success</title>
          <description>Medtronic CoreValve® System subjects only.
Defined as device success and absence of in-hospital MACCE.</description>
          <population>Participant Population= Consisted of all subjects with a TAVR index procedure who were evaluable for procedural success.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="476"/>
                <count group_id="O2" value="142"/>
                <count group_id="O3" value="384"/>
                <count group_id="O4" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="77.5"/>
                    <measurement group_id="O2" value="77.5"/>
                    <measurement group_id="O3" value="81.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Prosthetic Valve Dysfunction (PVD)</title>
        <description>PVD was defined according to VARC I using the Core Lab Echocardiography assessments including aortic regurgitation (AR) and aortic stenosis (AS) evaluations. Total AR reported as moderate or severe was considered PVD. AS was defined as significant stenosis and considered PVD if one of the following was met:
Peak velocity &gt;4 m/s
Mean gradient &gt;35 mmHg
EOA &lt; 0.8 cm2
TVIV1 / TVIV2 &lt; 0.25</description>
        <time_frame>30 day, 6 month, 1 year, 2 year</time_frame>
        <population>Participant Population= Consisted of all subjects with a valve implanted.</population>
        <group_list>
          <group group_id="O1">
            <title>Extreme Risk: TAVI Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Iliofemoral Access</description>
          </group>
          <group group_id="O2">
            <title>Extreme Risk: TAVI Non-Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Non-Iliofemoral Access</description>
          </group>
          <group group_id="O3">
            <title>High Risk: TAVI</title>
            <description>High Risk Surgical Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O4">
            <title>High Risk: SAVR</title>
            <description>High Risk Surgical Patients: Surgical Aortic Valve Replacement (SAVR)</description>
          </group>
        </group_list>
        <measure>
          <title>Prosthetic Valve Dysfunction (PVD)</title>
          <description>PVD was defined according to VARC I using the Core Lab Echocardiography assessments including aortic regurgitation (AR) and aortic stenosis (AS) evaluations. Total AR reported as moderate or severe was considered PVD. AS was defined as significant stenosis and considered PVD if one of the following was met:
Peak velocity &gt;4 m/s
Mean gradient &gt;35 mmHg
EOA &lt; 0.8 cm2
TVIV1 / TVIV2 &lt; 0.25</description>
          <population>Participant Population= Consisted of all subjects with a valve implanted.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="486"/>
                <count group_id="O2" value="148"/>
                <count group_id="O3" value="390"/>
                <count group_id="O4" value="354"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>30 day Aortic Stenosis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.3"/>
                    <measurement group_id="O2" value="6.1"/>
                    <measurement group_id="O3" value="3.1"/>
                    <measurement group_id="O4" value="4.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 day Aortic Regurgitation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23.5"/>
                    <measurement group_id="O2" value="16.9"/>
                    <measurement group_id="O3" value="13.6"/>
                    <measurement group_id="O4" value="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month Aortic Stenosis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.1"/>
                    <measurement group_id="O2" value="6.1"/>
                    <measurement group_id="O3" value="3.8"/>
                    <measurement group_id="O4" value="6.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month Aortic Regurgitation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.1"/>
                    <measurement group_id="O2" value="18.2"/>
                    <measurement group_id="O3" value="17.2"/>
                    <measurement group_id="O4" value="2.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year Aortic Stenosis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.5"/>
                    <measurement group_id="O2" value="6.1"/>
                    <measurement group_id="O3" value="4.9"/>
                    <measurement group_id="O4" value="8.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year Aortic Regurgitation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27.0"/>
                    <measurement group_id="O2" value="19.6"/>
                    <measurement group_id="O3" value="17.9"/>
                    <measurement group_id="O4" value="2.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 year Aortic Stenosis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.9"/>
                    <measurement group_id="O2" value="6.8"/>
                    <measurement group_id="O3" value="5.4"/>
                    <measurement group_id="O4" value="9.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 year Aortic Regurgitation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27.8"/>
                    <measurement group_id="O2" value="19.6"/>
                    <measurement group_id="O3" value="19.7"/>
                    <measurement group_id="O4" value="2.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events (AEs) were collected from study enrollment to study closure, up to 5 years. Adverse event data are currently available and reported for up to 1 year</time_frame>
      <desc>All new or worsening AEs were collected through12 months.</desc>
      <group_list>
        <group group_id="E1">
          <title>Extreme Risk: TAVI Iliofemoral</title>
          <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Iliofemoral Access</description>
        </group>
        <group group_id="E2">
          <title>Extreme Risk: TAVI Non-Iliofemoral</title>
          <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Non-Iliofemoral Access</description>
        </group>
        <group group_id="E3">
          <title>High Risk: TAVI</title>
          <description>High Risk Surgical Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
        </group>
        <group group_id="E4">
          <title>High Risk: SAVR</title>
          <description>High Risk Surgical Patients: Surgical Aortic Valve Replacement (SAVR)</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA 14.1</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="452" subjects_at_risk="489"/>
                <counts group_id="E2" subjects_affected="142" subjects_at_risk="150"/>
                <counts group_id="E3" subjects_affected="346" subjects_at_risk="390"/>
                <counts group_id="E4" subjects_affected="324" subjects_at_risk="357"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia Deficiencies</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Anaemias Due To Chronic Disorders</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Anaemias Haemolytic Immune</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Anaemias Nec</sub_title>
                <counts group_id="E1" events="170" subjects_affected="140" subjects_at_risk="489"/>
                <counts group_id="E2" events="75" subjects_affected="70" subjects_at_risk="150"/>
                <counts group_id="E3" events="132" subjects_affected="106" subjects_at_risk="390"/>
                <counts group_id="E4" events="173" subjects_affected="151" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Coagulopathies</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="489"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="4" subjects_affected="4" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Eosinophilic Disorders</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Haematological Disorders</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Leukocytoses Nec</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="390"/>
                <counts group_id="E4" events="4" subjects_affected="4" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Marrow Depression And Hypoplastic Anaemias</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Thrombocytopenias</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="489"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="150"/>
                <counts group_id="E3" events="8" subjects_affected="8" subjects_at_risk="390"/>
                <counts group_id="E4" events="22" subjects_affected="22" subjects_at_risk="357"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Aortic Valvular Disorders</sub_title>
                <counts group_id="E1" events="45" subjects_affected="44" subjects_at_risk="489"/>
                <counts group_id="E2" events="12" subjects_affected="12" subjects_at_risk="150"/>
                <counts group_id="E3" events="42" subjects_affected="42" subjects_at_risk="390"/>
                <counts group_id="E4" events="12" subjects_affected="10" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Cardiac Conduction Disorders</sub_title>
                <counts group_id="E1" events="109" subjects_affected="106" subjects_at_risk="489"/>
                <counts group_id="E2" events="27" subjects_affected="24" subjects_at_risk="150"/>
                <counts group_id="E3" events="85" subjects_affected="79" subjects_at_risk="390"/>
                <counts group_id="E4" events="19" subjects_affected="18" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Cardiac Disorders Nec</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="489"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="150"/>
                <counts group_id="E3" events="9" subjects_affected="7" subjects_at_risk="390"/>
                <counts group_id="E4" events="7" subjects_affected="7" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Cardiac Signs And Symptoms Nec</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="4" subjects_affected="4" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Cardiac Valve Disorders Nec</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Cardiomyopathies</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Coronary Artery Disorders Nec</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="489"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="150"/>
                <counts group_id="E3" events="9" subjects_affected="9" subjects_at_risk="390"/>
                <counts group_id="E4" events="4" subjects_affected="4" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Heart Failures Nec</sub_title>
                <counts group_id="E1" events="186" subjects_affected="117" subjects_at_risk="489"/>
                <counts group_id="E2" events="43" subjects_affected="29" subjects_at_risk="150"/>
                <counts group_id="E3" events="95" subjects_affected="69" subjects_at_risk="390"/>
                <counts group_id="E4" events="85" subjects_affected="62" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Ischaemic Coronary Artery Disorders</sub_title>
                <counts group_id="E1" events="30" subjects_affected="28" subjects_at_risk="489"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="150"/>
                <counts group_id="E3" events="17" subjects_affected="15" subjects_at_risk="390"/>
                <counts group_id="E4" events="15" subjects_affected="12" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Mitral Valvular Disorders</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="489"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="150"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="390"/>
                <counts group_id="E4" events="5" subjects_affected="5" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Myocardial Disorders Nec</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Noninfectious Pericarditis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Pericardial Disorders Nec</sub_title>
                <counts group_id="E1" events="7" subjects_affected="5" subjects_at_risk="489"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="150"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="390"/>
                <counts group_id="E4" events="10" subjects_affected="10" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Rate And Rhythm Disorders Nec</sub_title>
                <counts group_id="E1" events="29" subjects_affected="28" subjects_at_risk="489"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="150"/>
                <counts group_id="E3" events="18" subjects_affected="16" subjects_at_risk="390"/>
                <counts group_id="E4" events="19" subjects_affected="19" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Right Ventricular Failures</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Supraventricular Arrhythmias</sub_title>
                <counts group_id="E1" events="79" subjects_affected="65" subjects_at_risk="489"/>
                <counts group_id="E2" events="22" subjects_affected="17" subjects_at_risk="150"/>
                <counts group_id="E3" events="46" subjects_affected="43" subjects_at_risk="390"/>
                <counts group_id="E4" events="80" subjects_affected="69" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Tricuspid Valvular Disorders</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="489"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Ventricular Arrhythmias And Cardiac Arrest</sub_title>
                <counts group_id="E1" events="59" subjects_affected="48" subjects_at_risk="489"/>
                <counts group_id="E2" events="30" subjects_affected="26" subjects_at_risk="150"/>
                <counts group_id="E3" events="29" subjects_affected="27" subjects_at_risk="390"/>
                <counts group_id="E4" events="27" subjects_affected="27" subjects_at_risk="357"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Cardiac Septal Defects Congenital</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Coagulation Disorders Congenital</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Male Reproductive Tract Disorders Congenital</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Vascular Anomalies Congenital Nec</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Hearing Losses</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Ear Disorders Nec</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Inner Ear Signs And Symptoms</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Thyroid Neoplasms</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Blindness (Excl Colour Blindness)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Cataract Conditions</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Corneal Infections, Oedemas And Inflammations</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Lacrimal Disorders</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Retinal Bleeding And Vascular Disorders (Excl Retinopathy)</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Retinal Structural Change, Deposit And Degeneration</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Retinal, Choroid And Vitreous Infections And Inflammations</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Visual Disorders Nec</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal Wall Conditions Nec</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Acute And Chronic Pancreatitis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Anal And Rectal Ulcers And Perforation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Benign Neoplasms Gastrointestinal (Excl Oral Cavity)</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Colitis (Excl Infective)</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="489"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="4" subjects_affected="4" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Diaphragmatic Hernias</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Diarrhoea (Excl Infective)</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="489"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="150"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="390"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Diverticula</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Duodenal And Small Intestinal Stenosis And Obstruction</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="489"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="150"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="390"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Duodenal Ulcers And Perforation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Dyspeptic Signs And Symptoms</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Faecal Abnormalities Nec</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Flatulence, Bloating And Distension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Gastric And Oesophageal Haemorrhages</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Gastric Ulcers And Perforation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Gastritis (Excl Infective)</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="390"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Gastrointestinal And Abdominal Pains (Excl Oral And Throat)</sub_title>
                <counts group_id="E1" events="15" subjects_affected="13" subjects_at_risk="489"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="150"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="390"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Atonic And Hypomotility Disorders Nec</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="4" subjects_affected="3" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Fistulae</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Necrosis And Gangrene (Excl Gangrenous Hernia)</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Disorders Nec</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Signs And Symptoms Nec</sub_title>
                <counts group_id="E1" events="15" subjects_affected="15" subjects_at_risk="489"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="150"/>
                <counts group_id="E3" events="7" subjects_affected="7" subjects_at_risk="390"/>
                <counts group_id="E4" events="13" subjects_affected="12" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Spastic And Hypermotility Disorders</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Stenosis And Obstruction Nec</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="390"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Ulcers And Perforation, Site Unspecified</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Vascular Occlusion And Infarction</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Haemorrhoids And Gastrointestinal Varices (Excl Oesophageal)</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Inguinal Hernias</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Intestinal Haemorrhages</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="390"/>
                <counts group_id="E4" events="4" subjects_affected="4" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Intestinal Ulcers And Perforation Nec</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Nausea And Vomiting Symptoms</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="489"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="5" subjects_affected="3" subjects_at_risk="390"/>
                <counts group_id="E4" events="5" subjects_affected="5" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Non-Site Specific Gastrointestinal Haemorrhages</sub_title>
                <counts group_id="E1" events="40" subjects_affected="35" subjects_at_risk="489"/>
                <counts group_id="E2" events="20" subjects_affected="18" subjects_at_risk="150"/>
                <counts group_id="E3" events="29" subjects_affected="27" subjects_at_risk="390"/>
                <counts group_id="E4" events="17" subjects_affected="16" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Oesophageal Stenosis And Obstruction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Oesophageal Ulcers And Perforation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Oesophagitis (Excl Infective)</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Oral Soft Tissue Pain And Paraesthesia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Pancreatic Neoplasms</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Peritoneal And Retroperitoneal Disorders</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Peritoneal And Retroperitoneal Haemorrhages</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Umbilical Hernias</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Hepatic Fibrosis And Cirrhosis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Clostridia Infections</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="489"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="150"/>
                <counts group_id="E3" events="7" subjects_affected="6" subjects_at_risk="390"/>
                <counts group_id="E4" events="6" subjects_affected="6" subjects_at_risk="357"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Administration Site Reactions Nec</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Asthenic Conditions</sub_title>
                <counts group_id="E1" events="12" subjects_affected="11" subjects_at_risk="489"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="150"/>
                <counts group_id="E3" events="10" subjects_affected="9" subjects_at_risk="390"/>
                <counts group_id="E4" events="9" subjects_affected="9" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Body Temperature Altered</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Cardiac Complications Associated With Device</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Complications Associated With Device Nec</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Death And Sudden Death</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="489"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="150"/>
                <counts group_id="E3" events="6" subjects_affected="6" subjects_at_risk="390"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Device Issues Nec</sub_title>
                <counts group_id="E1" events="40" subjects_affected="40" subjects_at_risk="489"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="150"/>
                <counts group_id="E3" events="30" subjects_affected="28" subjects_at_risk="390"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Device Malfunction Events Nec</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="390"/>
                <counts group_id="E4" events="5" subjects_affected="5" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Febrile Disorders</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="489"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="150"/>
                <counts group_id="E3" events="7" subjects_affected="7" subjects_at_risk="390"/>
                <counts group_id="E4" events="6" subjects_affected="6" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Feelings And Sensations Nec</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Gait Disturbances</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>General Signs And Symptoms Nec</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="489"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="150"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="390"/>
                <counts group_id="E4" events="5" subjects_affected="5" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Healing Abnormal Nec</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Hernias Nec</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Implant And Catheter Site Reactions</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Inflammations</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Injection Site Reactions</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Mass Conditions Nec</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Oedema Nec</sub_title>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="7" subjects_affected="6" subjects_at_risk="390"/>
                <counts group_id="E4" events="6" subjects_affected="6" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Pain And Discomfort Nec</sub_title>
                <counts group_id="E1" events="33" subjects_affected="26" subjects_at_risk="489"/>
                <counts group_id="E2" events="11" subjects_affected="9" subjects_at_risk="150"/>
                <counts group_id="E3" events="29" subjects_affected="23" subjects_at_risk="390"/>
                <counts group_id="E4" events="22" subjects_affected="19" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Product Physical Issues</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Therapeutic And Nontherapeutic Responses</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Withdrawal And Rebound Effects</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Bile Duct Infections And Inflammations</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Cholecystitis And Cholelithiasis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Hepatic And Hepatobiliary Disorders Nec</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Hepatic Failure And Associated Disorders</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Hepatocellular Damage And Hepatitis Nec</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="357"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaphylactic Responses</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Abdominal And Gastrointestinal Infections</sub_title>
                <counts group_id="E1" events="8" subjects_affected="6" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="390"/>
                <counts group_id="E4" events="4" subjects_affected="4" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Atypical Mycobacterial Infections</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Bacterial Infections Nec</sub_title>
                <counts group_id="E1" events="25" subjects_affected="22" subjects_at_risk="489"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="150"/>
                <counts group_id="E3" events="20" subjects_affected="15" subjects_at_risk="390"/>
                <counts group_id="E4" events="12" subjects_affected="12" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Bone And Joint Infections</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Candida Infections</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Cardiac Infections</sub_title>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Central Nervous System And Spinal Infections</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Ear Infections</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Enterobacter Infections</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Enterococcal Infections</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Escherichia Infections</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Fungal Infections Nec</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Haemophilus Infections</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Herpes Viral Infections</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="150"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Infections Nec</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="489"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="150"/>
                <counts group_id="E3" events="6" subjects_affected="6" subjects_at_risk="390"/>
                <counts group_id="E4" events="8" subjects_affected="8" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Infectious Transmissions</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Influenza Viral Infections</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Klebsiella Infections</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Lower Respiratory Tract And Lung Infections</sub_title>
                <counts group_id="E1" events="95" subjects_affected="74" subjects_at_risk="489"/>
                <counts group_id="E2" events="26" subjects_affected="25" subjects_at_risk="150"/>
                <counts group_id="E3" events="48" subjects_affected="44" subjects_at_risk="390"/>
                <counts group_id="E4" events="43" subjects_affected="36" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Pseudomonal Infections</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Sepsis, Bacteraemia, Viraemia And Fungaemia Nec</sub_title>
                <counts group_id="E1" events="35" subjects_affected="32" subjects_at_risk="489"/>
                <counts group_id="E2" events="18" subjects_affected="17" subjects_at_risk="150"/>
                <counts group_id="E3" events="38" subjects_affected="32" subjects_at_risk="390"/>
                <counts group_id="E4" events="36" subjects_affected="29" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Staphylococcal Infections</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="489"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="150"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="390"/>
                <counts group_id="E4" events="4" subjects_affected="3" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Streptococcal Infections</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="489"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="150"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Upper Respiratory Tract Infections</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="150"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Urinary Tract Infections</sub_title>
                <counts group_id="E1" events="32" subjects_affected="28" subjects_at_risk="489"/>
                <counts group_id="E2" events="11" subjects_affected="9" subjects_at_risk="150"/>
                <counts group_id="E3" events="21" subjects_affected="21" subjects_at_risk="390"/>
                <counts group_id="E4" events="22" subjects_affected="20" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Vascular Infections</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Viral Infections Nec</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Anaesthetic Complications</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Cardiac And Vascular Procedural Complications</sub_title>
                <counts group_id="E1" events="17" subjects_affected="16" subjects_at_risk="489"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="150"/>
                <counts group_id="E3" events="7" subjects_affected="7" subjects_at_risk="390"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Cardiovascular Injuries</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="489"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Cerebral Injuries Nec</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="150"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="390"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Chest And Lung Injuries Nec</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Fractures And Dislocations Nec</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Gastrointestinal And Hepatobiliary Procedural Complications</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Limb Injuries Nec (Incl Traumatic Amputation)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Lower Limb Fractures And Dislocations</sub_title>
                <counts group_id="E1" events="19" subjects_affected="18" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="10" subjects_affected="9" subjects_at_risk="390"/>
                <counts group_id="E4" events="12" subjects_affected="10" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Non-Site Specific Injuries Nec</sub_title>
                <counts group_id="E1" events="13" subjects_affected="13" subjects_at_risk="489"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="150"/>
                <counts group_id="E3" events="16" subjects_affected="14" subjects_at_risk="390"/>
                <counts group_id="E4" events="6" subjects_affected="6" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Non-Site Specific Procedural Complications</sub_title>
                <counts group_id="E1" events="27" subjects_affected="25" subjects_at_risk="489"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="150"/>
                <counts group_id="E3" events="26" subjects_affected="25" subjects_at_risk="390"/>
                <counts group_id="E4" events="29" subjects_affected="28" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Pelvic Fractures And Dislocations</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="489"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="150"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Poisoning And Toxicity</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Radiation Injuries</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Reproductive System And Breast Injuries</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Respiratory Tract And Thoracic Cavity Procedural Complications</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Site Specific Injuries Nec</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Skin Injuries Nec</sub_title>
                <counts group_id="E1" events="11" subjects_affected="10" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="390"/>
                <counts group_id="E4" events="5" subjects_affected="5" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Skin Procedural Complications</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Skull Fractures, Facial Bone Fractures And Dislocations</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Spinal Fractures And Dislocations</sub_title>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="8" subjects_affected="5" subjects_at_risk="390"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Thoracic Cage Fractures And Dislocations</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Transfusion Related Complications</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Upper Limb Fractures And Dislocations</sub_title>
                <counts group_id="E1" events="11" subjects_affected="10" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="390"/>
                <counts group_id="E4" events="6" subjects_affected="5" subjects_at_risk="357"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Bacteria Identification And Serology (Excl Mycobacteria)</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Blood Counts Nec</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="489"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Blood Gas And Acid Base Analyses</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Carbohydrate Tolerance Analyses (Incl Diabetes)</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Cardiac Function Diagnostic Procedures</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="489"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="6" subjects_affected="6" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Coagulation And Bleeding Analyses</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="489"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="150"/>
                <counts group_id="E3" events="6" subjects_affected="6" subjects_at_risk="390"/>
                <counts group_id="E4" events="7" subjects_affected="6" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Ecg Investigations</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Liver Function Analyses</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Metabolism Tests Nec</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Microbiology And Serology Tests Nec</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Mineral And Electrolyte Analyses</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Physical Examination Procedures</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="390"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Platelet Analyses</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Protein Analyses Nec</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Red Blood Cell Analyses</sub_title>
                <counts group_id="E1" events="13" subjects_affected="13" subjects_at_risk="489"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="150"/>
                <counts group_id="E3" events="10" subjects_affected="10" subjects_at_risk="390"/>
                <counts group_id="E4" events="11" subjects_affected="11" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Renal Function Analyses</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Respiratory Tract And Thoracic Imaging Procedures</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Skeletal And Cardiac Muscle Analyses</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="489"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="5" subjects_affected="5" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Tissue Enzyme Analyses Nec</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Urinalysis Nec</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Urinary Tract Function Analyses Nec</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="489"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Vascular Tests Nec (Incl Blood Pressure)</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>White Blood Cell Analyses</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Appetite Disorders</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Calcium Metabolism Disorders</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="390"/>
                <counts group_id="E4" events="2" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Diabetes Mellitus (Incl Subtypes)</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Diabetic Complications Dermal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Diabetic Complications Nec</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Disorders Of Purine Metabolism</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Electrolyte Imbalance Nec</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>General Nutritional Disorders Nec</sub_title>
                <counts group_id="E1" events="20" subjects_affected="18" subjects_at_risk="489"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="150"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="390"/>
                <counts group_id="E4" events="16" subjects_affected="15" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Hyperglycaemic Conditions Nec</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="390"/>
                <counts group_id="E4" events="6" subjects_affected="6" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Hypoglycaemic Conditions Nec</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="489"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="150"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="390"/>
                <counts group_id="E4" events="4" subjects_affected="4" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Magnesium Metabolism Disorders</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Metabolic Acidoses (Excl Diabetic Acidoses)</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="489"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="4" subjects_affected="4" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Metabolic Alkaloses</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Mixed Acid-Base Disorders</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Potassium Imbalance</sub_title>
                <counts group_id="E1" events="15" subjects_affected="14" subjects_at_risk="489"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="150"/>
                <counts group_id="E3" events="8" subjects_affected="8" subjects_at_risk="390"/>
                <counts group_id="E4" events="6" subjects_affected="5" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Protein Metabolism Disorders Nec</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Sodium Imbalance</sub_title>
                <counts group_id="E1" events="10" subjects_affected="8" subjects_at_risk="489"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="150"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="390"/>
                <counts group_id="E4" events="5" subjects_affected="5" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Total Fluid Volume Decreased</sub_title>
                <counts group_id="E1" events="15" subjects_affected="15" subjects_at_risk="489"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="150"/>
                <counts group_id="E3" events="9" subjects_affected="8" subjects_at_risk="390"/>
                <counts group_id="E4" events="15" subjects_affected="14" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Total Fluid Volume Increased</sub_title>
                <counts group_id="E1" events="13" subjects_affected="12" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="7" subjects_affected="7" subjects_at_risk="390"/>
                <counts group_id="E4" events="12" subjects_affected="11" subjects_at_risk="357"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthropathies Nec</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Bone Disorders Nec</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Bone Related Signs And Symptoms</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Joint Related Signs And Symptoms</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Metabolic Bone Disorders</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Muscle Weakness Conditions</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Musculoskeletal And Connective Tissue Pain And Discomfort</sub_title>
                <counts group_id="E1" events="9" subjects_affected="8" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="15" subjects_affected="13" subjects_at_risk="390"/>
                <counts group_id="E4" events="7" subjects_affected="7" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Musculoskeletal And Connective Tissue Signs And Symptoms Nec</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Myopathies</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Osteoarthropathies</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="150"/>
                <counts group_id="E3" events="4" subjects_affected="3" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Spine And Neck Deformities</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>B-Cell Lymphomas Nec</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Bladder Neoplasms Malignant</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Breast And Nipple Neoplasms Malignant</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Colonic Neoplasms Malignant</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Gastric Neoplasms Malignant</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Neoplasms Malignancy Unspecified Nec</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Hepatic Neoplasms Malignant</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Leukaemias Acute Myeloid</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Multiple Myelomas</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Myelodysplastic Syndromes</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Neoplasms Malignant Site Unspecified Nec</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="390"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Neuromas</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Pancreatic Neoplasms Malignant (Excl Islet Cell And Carcinoid)</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Pharyngeal And Laryngeal Neoplasms Benign</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Prostatic Neoplasms Malignant</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Renal Neoplasms Malignant</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Respiratory Tract And Pleural Neoplasms Malignant Cell Type Unspecified Nec</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Skin Neoplasms Malignant And Unspecified (Excl Melanoma)</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="390"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Thyroid Neoplasms Malignant</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Acute Polyneuropathies</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Central Nervous System Haemorrhages And Cerebrovascular Accidents</sub_title>
                <counts group_id="E1" events="28" subjects_affected="28" subjects_at_risk="489"/>
                <counts group_id="E2" events="14" subjects_affected="14" subjects_at_risk="150"/>
                <counts group_id="E3" events="30" subjects_affected="26" subjects_at_risk="390"/>
                <counts group_id="E4" events="35" subjects_affected="32" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Central Nervous System Vascular Disorders Nec</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Cerebellar Coordination And Balance Disturbances</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Coma States</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Cortical Dysfunction Nec</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Dementia (Excl Alzheimer's Type)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Disturbances In Consciousness Nec</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="489"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="150"/>
                <counts group_id="E3" events="15" subjects_affected="14" subjects_at_risk="390"/>
                <counts group_id="E4" events="8" subjects_affected="7" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Dyskinesias And Movement Disorders Nec</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Encephalopathies Nec</sub_title>
                <counts group_id="E1" events="14" subjects_affected="14" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="390"/>
                <counts group_id="E4" events="5" subjects_affected="5" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Encephalopathies Toxic And Metabolic</sub_title>
                <counts group_id="E1" events="11" subjects_affected="8" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="390"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Headaches Nec</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Hydrocephalic Conditions</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Increased Intracranial Pressure Disorders</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Lumbar Spinal Cord And Nerve Root Disorders</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Memory Loss (Excl Dementia)</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Migraine Headaches</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Mononeuropathies</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Nervous System Disorders Nec</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Neurological Signs And Symptoms Nec</sub_title>
                <counts group_id="E1" events="8" subjects_affected="7" subjects_at_risk="489"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="150"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="390"/>
                <counts group_id="E4" events="11" subjects_affected="11" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Neuromuscular Junction Dysfunction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Paralysis And Paresis (Excl Cranial Nerve)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Peripheral Neuropathies Nec</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Seizures And Seizure Disorders Nec</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="489"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="10" subjects_affected="10" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Sensory Abnormalities Nec</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Speech And Language Abnormalities</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Transient Cerebrovascular Events</sub_title>
                <counts group_id="E1" events="8" subjects_affected="7" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="6" subjects_affected="6" subjects_at_risk="390"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Tremor (Excl Congenital)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Vagus Nerve Disorders</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Anxiety Symptoms</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Behaviour And Socialisation Disturbances</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Confusion And Disorientation</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="9" subjects_affected="8" subjects_at_risk="390"/>
                <counts group_id="E4" events="4" subjects_affected="4" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Deliria</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Depressive Disorders</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="390"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Mental Disorders Nec</sub_title>
                <counts group_id="E1" events="13" subjects_affected="13" subjects_at_risk="489"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="150"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="390"/>
                <counts group_id="E4" events="14" subjects_affected="14" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Perception Disturbances</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Suicidal And Self-Injurious Behaviour</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Bladder And Urethral Symptoms</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="489"/>
                <counts group_id="E2" events="9" subjects_affected="8" subjects_at_risk="150"/>
                <counts group_id="E3" events="9" subjects_affected="8" subjects_at_risk="390"/>
                <counts group_id="E4" events="11" subjects_affected="9" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Bladder Disorders Nec</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Genital And Urinary Tract Disorders Nec</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Nephritis Nec</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Nephropathies And Tubular Disorders Nec</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Renal Disorders Nec</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Renal Failure And Impairment</sub_title>
                <counts group_id="E1" events="108" subjects_affected="90" subjects_at_risk="489"/>
                <counts group_id="E2" events="43" subjects_affected="31" subjects_at_risk="150"/>
                <counts group_id="E3" events="42" subjects_affected="38" subjects_at_risk="390"/>
                <counts group_id="E4" events="66" subjects_affected="58" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Renal Failure Complications</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Renal Lithiasis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Renal Obstructive Disorders</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Renal Vascular And Ischaemic Conditions</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Ureteric Disorders Nec</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Urinary Abnormalities</sub_title>
                <counts group_id="E1" events="13" subjects_affected="10" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="8" subjects_affected="8" subjects_at_risk="390"/>
                <counts group_id="E4" events="11" subjects_affected="6" subjects_at_risk="357"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Breast Disorders Nec</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Pelvic Prolapse Conditions</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Prostatic Neoplasms And Hypertrophy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Reproductive Tract Disorders Nec (Excl Neoplasms)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Scrotal Disorders Nec</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Vulvovaginal Disorders Nec</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Breathing Abnormalities</sub_title>
                <counts group_id="E1" events="27" subjects_affected="26" subjects_at_risk="489"/>
                <counts group_id="E2" events="29" subjects_affected="21" subjects_at_risk="150"/>
                <counts group_id="E3" events="33" subjects_affected="30" subjects_at_risk="390"/>
                <counts group_id="E4" events="31" subjects_affected="26" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Bronchial Conditions Nec</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Bronchospasm And Obstruction</sub_title>
                <counts group_id="E1" events="28" subjects_affected="25" subjects_at_risk="489"/>
                <counts group_id="E2" events="21" subjects_affected="16" subjects_at_risk="150"/>
                <counts group_id="E3" events="15" subjects_affected="13" subjects_at_risk="390"/>
                <counts group_id="E4" events="9" subjects_affected="8" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Conditions Associated With Abnormal Gas Exchange</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="6" subjects_affected="6" subjects_at_risk="390"/>
                <counts group_id="E4" events="6" subjects_affected="6" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Coughing And Associated Symptoms</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="6" subjects_affected="5" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Diaphragmatic Disorders</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Laryngeal And Adjacent Sites Disorders Nec (Excl Infections And Neoplasms)</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Laryngeal Spasm, Oedema And Obstruction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Lower Respiratory Tract Inflammatory And Immunologic Conditions</sub_title>
                <counts group_id="E1" events="9" subjects_affected="8" subjects_at_risk="489"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="150"/>
                <counts group_id="E3" events="7" subjects_affected="7" subjects_at_risk="390"/>
                <counts group_id="E4" events="8" subjects_affected="8" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Lower Respiratory Tract Signs And Symptoms</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Mediastinal Disorders</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Nasal Disorders Nec</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Parenchymal Lung Disorders Nec</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="489"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="150"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="390"/>
                <counts group_id="E4" events="4" subjects_affected="4" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Pharyngeal Disorders (Excl Infections And Neoplasms)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Pneumothorax And Pleural Effusions Nec</sub_title>
                <counts group_id="E1" events="74" subjects_affected="54" subjects_at_risk="489"/>
                <counts group_id="E2" events="36" subjects_affected="26" subjects_at_risk="150"/>
                <counts group_id="E3" events="39" subjects_affected="29" subjects_at_risk="390"/>
                <counts group_id="E4" events="86" subjects_affected="67" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Pulmonary Hypertensions</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Pulmonary Oedemas</sub_title>
                <counts group_id="E1" events="24" subjects_affected="23" subjects_at_risk="489"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="150"/>
                <counts group_id="E3" events="9" subjects_affected="9" subjects_at_risk="390"/>
                <counts group_id="E4" events="10" subjects_affected="10" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Pulmonary Thrombotic And Embolic Conditions</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Respiratory Failures (Excl Neonatal)</sub_title>
                <counts group_id="E1" events="62" subjects_affected="54" subjects_at_risk="489"/>
                <counts group_id="E2" events="29" subjects_affected="28" subjects_at_risk="150"/>
                <counts group_id="E3" events="40" subjects_affected="36" subjects_at_risk="390"/>
                <counts group_id="E4" events="68" subjects_affected="54" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Respiratory Tract Disorders Nec</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="390"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Tracheal Disorders (Excl Infections And Neoplasms)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Upper Respiratory Tract Signs And Symptoms</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Bullous Conditions</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Dermal And Epidermal Conditions Nec</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Dermatitis And Eczema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Dermatitis Ascribed To Specific Agent</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Purpura And Related Conditions</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Rashes, Eruptions And Exanthems Nec</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Skin And Subcutaneous Tissue Ulcerations</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Skin Haemorrhages</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Skin Injuries And Mechanical Dermatoses</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="6" subjects_affected="6" subjects_at_risk="390"/>
                <counts group_id="E4" events="4" subjects_affected="4" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Skin Preneoplastic Conditions Nec</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title>Housing Circumstances</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Cardiac Device Therapeutic Procedures</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Corneal And Scleral Therapeutic Procedures</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Fracture Treatments (Excl Skull And Spine)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Hernia Repairs</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Joint Therapeutic Procedures</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Lens Therapeutic Procedures</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Limb Therapeutic Procedures</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Muscle Therapeutic Procedures</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Prophylactic Procedures Nec</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Renal Therapeutic Procedures</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Therapeutic Procedures Nec</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="390"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Tracheal Therapeutic Procedures</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Ureteric Therapeutic Procedures</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Accelerated And Malignant Hypertension</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="489"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Aneurysms And Dissections Non-Site Specific</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Aortic Aneurysms And Dissections</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="489"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="5" subjects_affected="5" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Aortic Necrosis And Vascular Insufficiency</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Arterial And Aortic Injuries</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Blood Pressure Disorders Nec</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Circulatory Collapse And Shock</sub_title>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="489"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="150"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="390"/>
                <counts group_id="E4" events="4" subjects_affected="4" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Haemorrhages Nec</sub_title>
                <counts group_id="E1" events="24" subjects_affected="20" subjects_at_risk="489"/>
                <counts group_id="E2" events="13" subjects_affected="13" subjects_at_risk="150"/>
                <counts group_id="E3" events="19" subjects_affected="19" subjects_at_risk="390"/>
                <counts group_id="E4" events="11" subjects_affected="10" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Lymphangiopathies</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="3" subjects_affected="2" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Lymphoedemas</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Non-Site Specific Embolism And Thrombosis</sub_title>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="390"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Non-Site Specific Necrosis And Vascular Insufficiency Nec</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="489"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="150"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="390"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Non-Site Specific Vascular Disorders Nec</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Peripheral Aneurysms And Dissections</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="9" subjects_affected="9" subjects_at_risk="390"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Peripheral Embolism And Thrombosis</sub_title>
                <counts group_id="E1" events="22" subjects_affected="21" subjects_at_risk="489"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="150"/>
                <counts group_id="E3" events="7" subjects_affected="7" subjects_at_risk="390"/>
                <counts group_id="E4" events="6" subjects_affected="5" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Peripheral Vascular Disorders Nec</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="3" subjects_affected="2" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Peripheral Vasoconstriction, Necrosis And Vascular Insufficiency</sub_title>
                <counts group_id="E1" events="18" subjects_affected="16" subjects_at_risk="489"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="150"/>
                <counts group_id="E3" events="12" subjects_affected="12" subjects_at_risk="390"/>
                <counts group_id="E4" events="3" subjects_affected="2" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Site Specific Vascular Disorders Nec</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="489"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="7" subjects_affected="6" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Varicose Veins Non-Site Specific</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Vascular Hypertensive Disorders Nec</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="489"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="150"/>
                <counts group_id="E3" events="15" subjects_affected="14" subjects_at_risk="390"/>
                <counts group_id="E4" events="7" subjects_affected="7" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Vascular Hypotensive Disorders</sub_title>
                <counts group_id="E1" events="54" subjects_affected="52" subjects_at_risk="489"/>
                <counts group_id="E2" events="15" subjects_affected="15" subjects_at_risk="150"/>
                <counts group_id="E3" events="23" subjects_affected="21" subjects_at_risk="390"/>
                <counts group_id="E4" events="40" subjects_affected="38" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Vascular Malformations And Acquired Anomalies</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="489"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="390"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="357"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA 14.1</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="440" subjects_at_risk="489"/>
                <counts group_id="E2" subjects_affected="139" subjects_at_risk="150"/>
                <counts group_id="E3" subjects_affected="355" subjects_at_risk="390"/>
                <counts group_id="E4" subjects_affected="320" subjects_at_risk="357"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemias Nec</sub_title>
                <counts group_id="E1" events="98" subjects_affected="90" subjects_at_risk="489"/>
                <counts group_id="E2" events="28" subjects_affected="27" subjects_at_risk="150"/>
                <counts group_id="E3" events="77" subjects_affected="76" subjects_at_risk="390"/>
                <counts group_id="E4" events="78" subjects_affected="69" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Leukocytoses Nec</sub_title>
                <counts group_id="E1" events="42" subjects_affected="38" subjects_at_risk="489"/>
                <counts group_id="E2" events="19" subjects_affected="18" subjects_at_risk="150"/>
                <counts group_id="E3" events="26" subjects_affected="25" subjects_at_risk="390"/>
                <counts group_id="E4" events="49" subjects_affected="46" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Thrombocytopenias</sub_title>
                <counts group_id="E1" events="73" subjects_affected="68" subjects_at_risk="489"/>
                <counts group_id="E2" events="33" subjects_affected="32" subjects_at_risk="150"/>
                <counts group_id="E3" events="64" subjects_affected="61" subjects_at_risk="390"/>
                <counts group_id="E4" events="95" subjects_affected="90" subjects_at_risk="357"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Cardiac Conduction Disorders</sub_title>
                <counts group_id="E1" events="137" subjects_affected="114" subjects_at_risk="489"/>
                <counts group_id="E2" events="37" subjects_affected="32" subjects_at_risk="150"/>
                <counts group_id="E3" events="100" subjects_affected="80" subjects_at_risk="390"/>
                <counts group_id="E4" events="68" subjects_affected="54" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Heart Failures Nec</sub_title>
                <counts group_id="E1" events="32" subjects_affected="30" subjects_at_risk="489"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="150"/>
                <counts group_id="E3" events="22" subjects_affected="20" subjects_at_risk="390"/>
                <counts group_id="E4" events="24" subjects_affected="21" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Rate And Rhythm Disorders Nec</sub_title>
                <counts group_id="E1" events="30" subjects_affected="29" subjects_at_risk="489"/>
                <counts group_id="E2" events="13" subjects_affected="12" subjects_at_risk="150"/>
                <counts group_id="E3" events="22" subjects_affected="21" subjects_at_risk="390"/>
                <counts group_id="E4" events="31" subjects_affected="30" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Supraventricular Arrhythmias</sub_title>
                <counts group_id="E1" events="66" subjects_affected="60" subjects_at_risk="489"/>
                <counts group_id="E2" events="42" subjects_affected="36" subjects_at_risk="150"/>
                <counts group_id="E3" events="69" subjects_affected="59" subjects_at_risk="390"/>
                <counts group_id="E4" events="91" subjects_affected="80" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Ventricular Arrhythmias And Cardiac Arrest</sub_title>
                <counts group_id="E1" events="33" subjects_affected="31" subjects_at_risk="489"/>
                <counts group_id="E2" events="10" subjects_affected="8" subjects_at_risk="150"/>
                <counts group_id="E3" events="22" subjects_affected="22" subjects_at_risk="390"/>
                <counts group_id="E4" events="9" subjects_affected="9" subjects_at_risk="357"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Gastrointestinal Atonic And Hypomotility Disorders Nec</sub_title>
                <counts group_id="E1" events="37" subjects_affected="36" subjects_at_risk="489"/>
                <counts group_id="E2" events="12" subjects_affected="12" subjects_at_risk="150"/>
                <counts group_id="E3" events="22" subjects_affected="22" subjects_at_risk="390"/>
                <counts group_id="E4" events="24" subjects_affected="24" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Nausea And Vomiting Symptoms</sub_title>
                <counts group_id="E1" events="33" subjects_affected="26" subjects_at_risk="489"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="150"/>
                <counts group_id="E3" events="25" subjects_affected="23" subjects_at_risk="390"/>
                <counts group_id="E4" events="21" subjects_affected="16" subjects_at_risk="357"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Febrile Disorders</sub_title>
                <counts group_id="E1" events="39" subjects_affected="36" subjects_at_risk="489"/>
                <counts group_id="E2" events="8" subjects_affected="7" subjects_at_risk="150"/>
                <counts group_id="E3" events="16" subjects_affected="16" subjects_at_risk="390"/>
                <counts group_id="E4" events="16" subjects_affected="16" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Oedema Nec</sub_title>
                <counts group_id="E1" events="48" subjects_affected="44" subjects_at_risk="489"/>
                <counts group_id="E2" events="18" subjects_affected="16" subjects_at_risk="150"/>
                <counts group_id="E3" events="35" subjects_affected="34" subjects_at_risk="390"/>
                <counts group_id="E4" events="31" subjects_affected="26" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Pain And Discomfort Nec</sub_title>
                <counts group_id="E1" events="34" subjects_affected="30" subjects_at_risk="489"/>
                <counts group_id="E2" events="10" subjects_affected="9" subjects_at_risk="150"/>
                <counts group_id="E3" events="30" subjects_affected="26" subjects_at_risk="390"/>
                <counts group_id="E4" events="33" subjects_affected="30" subjects_at_risk="357"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Lower Respiratory Tract And Lung Infections</sub_title>
                <counts group_id="E1" events="26" subjects_affected="26" subjects_at_risk="489"/>
                <counts group_id="E2" events="16" subjects_affected="16" subjects_at_risk="150"/>
                <counts group_id="E3" events="19" subjects_affected="18" subjects_at_risk="390"/>
                <counts group_id="E4" events="23" subjects_affected="21" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Urinary Tract Infections</sub_title>
                <counts group_id="E1" events="80" subjects_affected="75" subjects_at_risk="489"/>
                <counts group_id="E2" events="34" subjects_affected="28" subjects_at_risk="150"/>
                <counts group_id="E3" events="59" subjects_affected="51" subjects_at_risk="390"/>
                <counts group_id="E4" events="67" subjects_affected="58" subjects_at_risk="357"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Non-Site Specific Injuries Nec</sub_title>
                <counts group_id="E1" events="26" subjects_affected="25" subjects_at_risk="489"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="150"/>
                <counts group_id="E3" events="23" subjects_affected="21" subjects_at_risk="390"/>
                <counts group_id="E4" events="15" subjects_affected="11" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Non-Site Specific Procedural Complications</sub_title>
                <counts group_id="E1" events="23" subjects_affected="21" subjects_at_risk="489"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="150"/>
                <counts group_id="E3" events="21" subjects_affected="20" subjects_at_risk="390"/>
                <counts group_id="E4" events="29" subjects_affected="29" subjects_at_risk="357"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Skeletal And Cardiac Muscle Analyses</sub_title>
                <counts group_id="E1" events="16" subjects_affected="16" subjects_at_risk="489"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="150"/>
                <counts group_id="E3" events="15" subjects_affected="15" subjects_at_risk="390"/>
                <counts group_id="E4" events="19" subjects_affected="19" subjects_at_risk="357"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Hyperglycaemic Conditions Nec</sub_title>
                <counts group_id="E1" events="22" subjects_affected="22" subjects_at_risk="489"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="150"/>
                <counts group_id="E3" events="19" subjects_affected="19" subjects_at_risk="390"/>
                <counts group_id="E4" events="30" subjects_affected="29" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Magnesium Metabolism Disorders</sub_title>
                <counts group_id="E1" events="17" subjects_affected="17" subjects_at_risk="489"/>
                <counts group_id="E2" events="10" subjects_affected="9" subjects_at_risk="150"/>
                <counts group_id="E3" events="6" subjects_affected="6" subjects_at_risk="390"/>
                <counts group_id="E4" events="9" subjects_affected="9" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Potassium Imbalance</sub_title>
                <counts group_id="E1" events="63" subjects_affected="56" subjects_at_risk="489"/>
                <counts group_id="E2" events="25" subjects_affected="16" subjects_at_risk="150"/>
                <counts group_id="E3" events="38" subjects_affected="36" subjects_at_risk="390"/>
                <counts group_id="E4" events="37" subjects_affected="33" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Sodium Imbalance</sub_title>
                <counts group_id="E1" events="26" subjects_affected="25" subjects_at_risk="489"/>
                <counts group_id="E2" events="13" subjects_affected="10" subjects_at_risk="150"/>
                <counts group_id="E3" events="22" subjects_affected="22" subjects_at_risk="390"/>
                <counts group_id="E4" events="29" subjects_affected="28" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Total Fluid Volume Increased</sub_title>
                <counts group_id="E1" events="20" subjects_affected="20" subjects_at_risk="489"/>
                <counts group_id="E2" events="13" subjects_affected="12" subjects_at_risk="150"/>
                <counts group_id="E3" events="21" subjects_affected="21" subjects_at_risk="390"/>
                <counts group_id="E4" events="43" subjects_affected="41" subjects_at_risk="357"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Musculoskeletal And Connective Tissue Pain And Discomfort</sub_title>
                <counts group_id="E1" events="42" subjects_affected="34" subjects_at_risk="489"/>
                <counts group_id="E2" events="19" subjects_affected="16" subjects_at_risk="150"/>
                <counts group_id="E3" events="39" subjects_affected="34" subjects_at_risk="390"/>
                <counts group_id="E4" events="22" subjects_affected="22" subjects_at_risk="357"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Neurological Signs And Symptoms Nec</sub_title>
                <counts group_id="E1" events="20" subjects_affected="18" subjects_at_risk="489"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="150"/>
                <counts group_id="E3" events="22" subjects_affected="21" subjects_at_risk="390"/>
                <counts group_id="E4" events="21" subjects_affected="17" subjects_at_risk="357"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Anxiety Symptoms</sub_title>
                <counts group_id="E1" events="25" subjects_affected="25" subjects_at_risk="489"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="150"/>
                <counts group_id="E3" events="14" subjects_affected="14" subjects_at_risk="390"/>
                <counts group_id="E4" events="14" subjects_affected="14" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Confusion And Disorientation</sub_title>
                <counts group_id="E1" events="34" subjects_affected="32" subjects_at_risk="489"/>
                <counts group_id="E2" events="14" subjects_affected="13" subjects_at_risk="150"/>
                <counts group_id="E3" events="25" subjects_affected="24" subjects_at_risk="390"/>
                <counts group_id="E4" events="25" subjects_affected="23" subjects_at_risk="357"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Renal Failure And Impairment</sub_title>
                <counts group_id="E1" events="78" subjects_affected="67" subjects_at_risk="489"/>
                <counts group_id="E2" events="20" subjects_affected="16" subjects_at_risk="150"/>
                <counts group_id="E3" events="43" subjects_affected="40" subjects_at_risk="390"/>
                <counts group_id="E4" events="51" subjects_affected="44" subjects_at_risk="357"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Pneumothorax And Pleural Effusions Nec</sub_title>
                <counts group_id="E1" events="82" subjects_affected="76" subjects_at_risk="489"/>
                <counts group_id="E2" events="32" subjects_affected="30" subjects_at_risk="150"/>
                <counts group_id="E3" events="58" subjects_affected="52" subjects_at_risk="390"/>
                <counts group_id="E4" events="105" subjects_affected="91" subjects_at_risk="357"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Breathing Abnormalities</sub_title>
                <counts group_id="E1" events="26" subjects_affected="26" subjects_at_risk="489"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="150"/>
                <counts group_id="E3" events="29" subjects_affected="27" subjects_at_risk="390"/>
                <counts group_id="E4" events="16" subjects_affected="14" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Bronchospasm And Obstruction</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="489"/>
                <counts group_id="E2" events="11" subjects_affected="10" subjects_at_risk="150"/>
                <counts group_id="E3" events="5" subjects_affected="4" subjects_at_risk="390"/>
                <counts group_id="E4" events="10" subjects_affected="10" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Conditions Associated With Abnormal Gas Exchange</sub_title>
                <counts group_id="E1" events="12" subjects_affected="12" subjects_at_risk="489"/>
                <counts group_id="E2" events="11" subjects_affected="8" subjects_at_risk="150"/>
                <counts group_id="E3" events="12" subjects_affected="11" subjects_at_risk="390"/>
                <counts group_id="E4" events="11" subjects_affected="11" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Parenchymal Lung Disorders Nec</sub_title>
                <counts group_id="E1" events="35" subjects_affected="35" subjects_at_risk="489"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="150"/>
                <counts group_id="E3" events="23" subjects_affected="23" subjects_at_risk="390"/>
                <counts group_id="E4" events="41" subjects_affected="41" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Pulmonary Oedemas</sub_title>
                <counts group_id="E1" events="29" subjects_affected="29" subjects_at_risk="489"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="150"/>
                <counts group_id="E3" events="20" subjects_affected="20" subjects_at_risk="390"/>
                <counts group_id="E4" events="27" subjects_affected="26" subjects_at_risk="357"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Haemorrhages Nec</sub_title>
                <counts group_id="E1" events="35" subjects_affected="34" subjects_at_risk="489"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="150"/>
                <counts group_id="E3" events="26" subjects_affected="26" subjects_at_risk="390"/>
                <counts group_id="E4" events="9" subjects_affected="9" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Vascular Hypertensive Disorders Nec</sub_title>
                <counts group_id="E1" events="49" subjects_affected="45" subjects_at_risk="489"/>
                <counts group_id="E2" events="20" subjects_affected="20" subjects_at_risk="150"/>
                <counts group_id="E3" events="55" subjects_affected="46" subjects_at_risk="390"/>
                <counts group_id="E4" events="40" subjects_affected="37" subjects_at_risk="357"/>
              </event>
              <event>
                <sub_title>Vascular Hypotensive Disorders</sub_title>
                <counts group_id="E1" events="73" subjects_affected="68" subjects_at_risk="489"/>
                <counts group_id="E2" events="21" subjects_affected="18" subjects_at_risk="150"/>
                <counts group_id="E3" events="41" subjects_affected="40" subjects_at_risk="390"/>
                <counts group_id="E4" events="43" subjects_affected="40" subjects_at_risk="357"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Hatice Bilgic Lim</name_or_title>
      <organization>Medtronic, Inc.</organization>
      <email>rs.medtroniccardiovascularclinicaltrials@medtronic.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

